Motif 216 (n=169)
Position-wise Probabilities
Download
uniprot | genes | site | source | protein | function |
---|---|---|---|---|---|
A0A0A6YYC7 | ZFP91-CNTF | S296 | ochoa | E3 ubiquitin-protein ligase ZFP91 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZFP91) (Zinc finger protein 91 homolog) | Atypical E3 ubiquitin-protein ligase that mediates 'Lys-63'-linked ubiquitination of MAP3K14/NIK, leading to stabilize and activate MAP3K14/NIK. It thereby acts as an activator of the non-canonical NF-kappa-B2/NFKB2 pathway. May also play an important role in cell proliferation and/or anti-apoptosis. {ECO:0000256|ARBA:ARBA00054990}. |
A4D1S0 | KLRG2 | S143 | ochoa | Killer cell lectin-like receptor subfamily G member 2 (C-type lectin domain family 15 member B) | None |
A6NEL2 | SOWAHB | S106 | ochoa | Ankyrin repeat domain-containing protein SOWAHB (Ankyrin repeat domain-containing protein 56) (Protein sosondowah homolog B) | None |
A6NI72 | NCF1B | S321 | ochoa | Putative neutrophil cytosol factor 1B (NCF-1B) (Putative SH3 and PX domain-containing protein 1B) | May be required for activation of the latent NADPH oxidase (necessary for superoxide production). {ECO:0000250}. |
A6NJU9 | NPIPB13 | S1100 | ochoa | Nuclear pore complex-interacting protein family member B13 | None |
A7MCY6 | TBKBP1 | S365 | ochoa | TANK-binding kinase 1-binding protein 1 (TBK1-binding protein 1) | Adapter protein which constitutively binds TBK1 and IKBKE playing a role in antiviral innate immunity. {ECO:0000269|PubMed:21931631}. |
A7MCY6 | TBKBP1 | S393 | ochoa | TANK-binding kinase 1-binding protein 1 (TBK1-binding protein 1) | Adapter protein which constitutively binds TBK1 and IKBKE playing a role in antiviral innate immunity. {ECO:0000269|PubMed:21931631}. |
A8CG34 | POM121C | S165 | ochoa | Nuclear envelope pore membrane protein POM 121C (Nuclear pore membrane protein 121-2) (POM121-2) (Pore membrane protein of 121 kDa C) | Essential component of the nuclear pore complex (NPC). The repeat-containing domain may be involved in anchoring components of the pore complex to the pore membrane. When overexpressed in cells induces the formation of cytoplasmic annulate lamellae (AL). {ECO:0000269|PubMed:17900573}. |
A8MRT5 | NPIPB5 | S1066 | ochoa | Nuclear pore complex-interacting protein family member B5 | None |
A8MVU1 | NCF1C | S296 | ochoa | Putative neutrophil cytosol factor 1C (NCF-1C) (Putative SH3 and PX domain-containing protein 1C) | May be required for activation of the latent NADPH oxidase (necessary for superoxide production). {ECO:0000250}. |
C9JG80 | NPIPB4 | S1071 | ochoa | Nuclear pore complex-interacting protein family member B4 | None |
E5RHQ5 | NPIPB11 | S1123 | ochoa | Nuclear pore complex-interacting protein family member B11 | None |
E7EW31 | PROB1 | S372 | ochoa | Proline-rich basic protein 1 | None |
O14654 | IRS4 | S439 | ochoa | Insulin receptor substrate 4 (IRS-4) (160 kDa phosphotyrosine protein) (py160) (Phosphoprotein of 160 kDa) (pp160) | Acts as an interface between multiple growth factor receptors possessing tyrosine kinase activity, such as insulin receptor, IGF1R and FGFR1, and a complex network of intracellular signaling molecules containing SH2 domains. Involved in the IGF1R mitogenic signaling pathway. Promotes the AKT1 signaling pathway and BAD phosphorylation during insulin stimulation without activation of RPS6KB1 or the inhibition of apoptosis. Interaction with GRB2 enhances insulin-stimulated mitogen-activated protein kinase activity. May be involved in nonreceptor tyrosine kinase signaling in myoblasts. Plays a pivotal role in the proliferation/differentiation of hepatoblastoma cell through EPHB2 activation upon IGF1 stimulation. May play a role in the signal transduction in response to insulin and to a lesser extent in response to IL4 and GH on mitogenesis. Plays a role in growth, reproduction and glucose homeostasis. May act as negative regulators of the IGF1 signaling pathway by suppressing the function of IRS1 and IRS2. {ECO:0000269|PubMed:10531310, ECO:0000269|PubMed:10594015, ECO:0000269|PubMed:12639902, ECO:0000269|PubMed:17408801, ECO:0000269|PubMed:9553137}. |
O14686 | KMT2D | S1307 | ochoa | Histone-lysine N-methyltransferase 2D (Lysine N-methyltransferase 2D) (EC 2.1.1.364) (ALL1-related protein) (Myeloid/lymphoid or mixed-lineage leukemia protein 2) | Histone methyltransferase that catalyzes methyl group transfer from S-adenosyl-L-methionine to the epsilon-amino group of 'Lys-4' of histone H3 (H3K4) (PubMed:25561738). Part of chromatin remodeling machinery predominantly forms H3K4me1 methylation marks at active chromatin sites where transcription and DNA repair take place (PubMed:17500065, PubMed:25561738). Acts as a coactivator for estrogen receptor by being recruited by ESR1, thereby activating transcription (PubMed:16603732). {ECO:0000269|PubMed:16603732, ECO:0000269|PubMed:17500065, ECO:0000269|PubMed:25561738}. |
O15534 | PER1 | S815 | ochoa | Period circadian protein homolog 1 (hPER1) (Circadian clock protein PERIOD 1) (Circadian pacemaker protein Rigui) | Transcriptional repressor which forms a core component of the circadian clock. The circadian clock, an internal time-keeping system, regulates various physiological processes through the generation of approximately 24 hour circadian rhythms in gene expression, which are translated into rhythms in metabolism and behavior. It is derived from the Latin roots 'circa' (about) and 'diem' (day) and acts as an important regulator of a wide array of physiological functions including metabolism, sleep, body temperature, blood pressure, endocrine, immune, cardiovascular, and renal function. Consists of two major components: the central clock, residing in the suprachiasmatic nucleus (SCN) of the brain, and the peripheral clocks that are present in nearly every tissue and organ system. Both the central and peripheral clocks can be reset by environmental cues, also known as Zeitgebers (German for 'timegivers'). The predominant Zeitgeber for the central clock is light, which is sensed by retina and signals directly to the SCN. The central clock entrains the peripheral clocks through neuronal and hormonal signals, body temperature and feeding-related cues, aligning all clocks with the external light/dark cycle. Circadian rhythms allow an organism to achieve temporal homeostasis with its environment at the molecular level by regulating gene expression to create a peak of protein expression once every 24 hours to control when a particular physiological process is most active with respect to the solar day. Transcription and translation of core clock components (CLOCK, NPAS2, BMAL1, BMAL2, PER1, PER2, PER3, CRY1 and CRY2) plays a critical role in rhythm generation, whereas delays imposed by post-translational modifications (PTMs) are important for determining the period (tau) of the rhythms (tau refers to the period of a rhythm and is the length, in time, of one complete cycle). A diurnal rhythm is synchronized with the day/night cycle, while the ultradian and infradian rhythms have a period shorter and longer than 24 hours, respectively. Disruptions in the circadian rhythms contribute to the pathology of cardiovascular diseases, cancer, metabolic syndromes and aging. A transcription/translation feedback loop (TTFL) forms the core of the molecular circadian clock mechanism. Transcription factors, CLOCK or NPAS2 and BMAL1 or BMAL2, form the positive limb of the feedback loop, act in the form of a heterodimer and activate the transcription of core clock genes and clock-controlled genes (involved in key metabolic processes), harboring E-box elements (5'-CACGTG-3') within their promoters. The core clock genes: PER1/2/3 and CRY1/2 which are transcriptional repressors form the negative limb of the feedback loop and interact with the CLOCK|NPAS2-BMAL1|BMAL2 heterodimer inhibiting its activity and thereby negatively regulating their own expression. This heterodimer also activates nuclear receptors NR1D1/2 and RORA/B/G, which form a second feedback loop and which activate and repress BMAL1 transcription, respectively. Regulates circadian target genes expression at post-transcriptional levels, but may not be required for the repression at transcriptional level. Controls PER2 protein decay. Represses CRY2 preventing its repression on CLOCK/BMAL1 target genes such as FXYD5 and SCNN1A in kidney and PPARA in liver. Besides its involvement in the maintenance of the circadian clock, has an important function in the regulation of several processes. Participates in the repression of glucocorticoid receptor NR3C1/GR-induced transcriptional activity by reducing the association of NR3C1/GR to glucocorticoid response elements (GREs) by BMAL1:CLOCK. Plays a role in the modulation of the neuroinflammatory state via the regulation of inflammatory mediators release, such as CCL2 and IL6. In spinal astrocytes, negatively regulates the MAPK14/p38 and MAPK8/JNK MAPK cascades as well as the subsequent activation of NFkappaB. Coordinately regulates the expression of multiple genes that are involved in the regulation of renal sodium reabsorption. Can act as gene expression activator in a gene and tissue specific manner, in kidney enhances WNK1 and SLC12A3 expression in collaboration with CLOCK. Modulates hair follicle cycling. Represses the CLOCK-BMAL1 induced transcription of BHLHE40/DEC1. {ECO:0000269|PubMed:24005054}. |
O43900 | PRICKLE3 | S482 | ochoa | Prickle planar cell polarity protein 3 (LIM domain only protein 6) (LMO-6) (Prickle-like protein 3) (Pk3) (Triple LIM domain protein 6) | Involved in the planar cell polarity (PCP) pathway that is essential for the polarization of epithelial cells during morphogenetic processes, including gastrulation and neurulation (By similarity). PCP is maintained by two molecular modules, the global and the core modules, PRICKLE3 being part of the core module (By similarity). Distinct complexes of the core module segregate to opposite sides of the cell, where they interact with the opposite complex in the neighboring cell at or near the adherents junctions (By similarity). Involved in the organization of the basal body (By similarity). Involved in cilia growth and positioning (By similarity). Required for proper assembly, stability, and function of mitochondrial membrane ATP synthase (mitochondrial complex V) (PubMed:32516135). {ECO:0000250|UniProtKB:A8WH69, ECO:0000269|PubMed:32516135}. |
O60716 | CTNND1 | S300 | ochoa | Catenin delta-1 (Cadherin-associated Src substrate) (CAS) (p120 catenin) (p120(ctn)) (p120(cas)) | Key regulator of cell-cell adhesion that associates with and regulates the cell adhesion properties of both C-, E- and N-cadherins, being critical for their surface stability (PubMed:14610055, PubMed:20371349). Promotes localization and retention of DSG3 at cell-cell junctions, via its interaction with DSG3 (PubMed:18343367). Beside cell-cell adhesion, regulates gene transcription through several transcription factors including ZBTB33/Kaiso2 and GLIS2, and the activity of Rho family GTPases and downstream cytoskeletal dynamics (PubMed:10207085, PubMed:20371349). Implicated both in cell transformation by SRC and in ligand-induced receptor signaling through the EGF, PDGF, CSF-1 and ERBB2 receptors (PubMed:17344476). {ECO:0000269|PubMed:10207085, ECO:0000269|PubMed:14610055, ECO:0000269|PubMed:17344476, ECO:0000269|PubMed:18343367, ECO:0000269|PubMed:20371349}. |
O60762 | DPM1 | S21 | ochoa | Dolichol-phosphate mannosyltransferase subunit 1 (EC 2.4.1.83) (Dolichol-phosphate mannose synthase subunit 1) (DPM synthase subunit 1) (Dolichyl-phosphate beta-D-mannosyltransferase subunit 1) (Mannose-P-dolichol synthase subunit 1) (MPD synthase subunit 1) | Transfers mannose from GDP-mannose to dolichol monophosphate to form dolichol phosphate mannose (Dol-P-Man) which is the mannosyl donor in pathways leading to N-glycosylation, glycosyl phosphatidylinositol membrane anchoring, and O-mannosylation of proteins; catalytic subunit of the dolichol-phosphate mannose (DPM) synthase complex. {ECO:0000269|PubMed:10835346}. |
O75815 | BCAR3 | S375 | ochoa | Breast cancer anti-estrogen resistance protein 3 (Novel SH2-containing protein 2) (SH2 domain-containing protein 3B) | Acts as an adapter protein downstream of several growth factor receptors to promote cell proliferation, migration, and redistribution of actin fibers (PubMed:24216110). Specifically involved in INS/insulin signaling pathway by mediating MAPK1/ERK2-MAPK3/ERK1 activation and DNA synthesis (PubMed:24216110). Promotes insulin-mediated membrane ruffling (By similarity). In response to vasoconstrictor peptide EDN1, involved in the activation of RAP1 downstream of PTK2B via interaction with phosphorylated BCAR1 (PubMed:19086031). Inhibits cell migration and invasion via regulation of TGFB-mediated matrix digestion, actin filament rearrangement, and inhibition of invadopodia activity (By similarity). May inhibit TGFB-SMAD signaling, via facilitating BCAR1 and SMAD2 and/or SMAD3 interaction (By similarity). Regulates EGF-induced DNA synthesis (PubMed:18722344). Required for the maintenance of ocular lens morphology and structural integrity, potentially via regulation of focal adhesion complex signaling (By similarity). Acts upstream of PTPRA to regulate the localization of BCAR1 and PTPRA to focal adhesions, via regulation of SRC-mediated phosphorylation of PTPRA (By similarity). Positively regulates integrin-induced tyrosine phosphorylation of BCAR1 (By similarity). Acts as a guanine nucleotide exchange factor (GEF) for small GTPases RALA, RAP1A and RRAS (By similarity). However, in a contrasting study, lacks GEF activity towards RAP1 (PubMed:22081014). {ECO:0000250|UniProtKB:D3ZAZ5, ECO:0000250|UniProtKB:Q9QZK2, ECO:0000269|PubMed:18722344, ECO:0000269|PubMed:19086031, ECO:0000269|PubMed:22081014, ECO:0000269|PubMed:24216110}. |
O76039 | CDKL5 | S543 | ochoa | Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) | Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175). {ECO:0000269|PubMed:15917271, ECO:0000269|PubMed:16935860, ECO:0000269|PubMed:29420175}. |
O76039 | CDKL5 | S720 | ochoa|psp | Cyclin-dependent kinase-like 5 (EC 2.7.11.22) (Serine/threonine-protein kinase 9) | Mediates phosphorylation of MECP2 (PubMed:15917271, PubMed:16935860). May regulate ciliogenesis (PubMed:29420175). {ECO:0000269|PubMed:15917271, ECO:0000269|PubMed:16935860, ECO:0000269|PubMed:29420175}. |
P14598 | NCF1 | S310 | psp | Neutrophil cytosol factor 1 (NCF-1) (47 kDa autosomal chronic granulomatous disease protein) (47 kDa neutrophil oxidase factor) (NCF-47K) (Neutrophil NADPH oxidase factor 1) (Nox organizer 2) (Nox-organizing protein 2) (SH3 and PX domain-containing protein 1A) (p47-phox) | Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:2547247, PubMed:2550933, PubMed:38355798). In the activated complex, electrons are first transferred from NADPH to flavin adenine dinucleotide (FAD) and subsequently transferred via two heme molecules to molecular oxygen, producing superoxide through an outer-sphere reaction (PubMed:38355798). Activation of the NADPH oxidase complex is initiated by the assembly of cytosolic subunits of the NADPH oxidase complex with the core NADPH oxidase complex to form a complex at the plasma membrane or phagosomal membrane (PubMed:38355798). This activation process is initiated by phosphorylation dependent binding of the cytosolic NCF1/p47-phox subunit to the C-terminus of CYBA/p22-phox (PubMed:12732142, PubMed:19801500). {ECO:0000269|PubMed:12732142, ECO:0000269|PubMed:19801500, ECO:0000269|PubMed:2547247, ECO:0000269|PubMed:2550933, ECO:0000269|PubMed:38355798}. |
P14598 | NCF1 | S320 | ochoa|psp | Neutrophil cytosol factor 1 (NCF-1) (47 kDa autosomal chronic granulomatous disease protein) (47 kDa neutrophil oxidase factor) (NCF-47K) (Neutrophil NADPH oxidase factor 1) (Nox organizer 2) (Nox-organizing protein 2) (SH3 and PX domain-containing protein 1A) (p47-phox) | Subunit of the phagocyte NADPH oxidase complex that mediates the transfer of electrons from cytosolic NADPH to O2 to produce the superoxide anion (O2(-)) (PubMed:2547247, PubMed:2550933, PubMed:38355798). In the activated complex, electrons are first transferred from NADPH to flavin adenine dinucleotide (FAD) and subsequently transferred via two heme molecules to molecular oxygen, producing superoxide through an outer-sphere reaction (PubMed:38355798). Activation of the NADPH oxidase complex is initiated by the assembly of cytosolic subunits of the NADPH oxidase complex with the core NADPH oxidase complex to form a complex at the plasma membrane or phagosomal membrane (PubMed:38355798). This activation process is initiated by phosphorylation dependent binding of the cytosolic NCF1/p47-phox subunit to the C-terminus of CYBA/p22-phox (PubMed:12732142, PubMed:19801500). {ECO:0000269|PubMed:12732142, ECO:0000269|PubMed:19801500, ECO:0000269|PubMed:2547247, ECO:0000269|PubMed:2550933, ECO:0000269|PubMed:38355798}. |
P28360 | MSX1 | S152 | ochoa | Homeobox protein MSX-1 (Homeobox protein Hox-7) (Msh homeobox 1-like protein) | Acts as a transcriptional repressor (By similarity). Capable of transcription autoinactivation (By similarity). Binds to the consensus sequence 5'-C/GTAAT-3' in downstream activin regulatory elements (DARE) in the gene promoter, thereby repressing the transcription of CGA/alpha-GSU and GNRHR (By similarity). Represses transcription of myoblast differentiation factors (By similarity). Binds to core enhancer regions in target gene promoters of myoblast differentiation factors with binding specificity facilitated by interaction with PIAS1 (By similarity). Regulates, in a stage-specific manner, a developmental program of gene expression in the fetal tooth bud that controls odontoblast differentiation and proliferation of dental mesenchymal cells (By similarity). At the bud stage, required for mesenchymal molar tooth bud development via facilitating reciprocal signaling between dental epithelial and mesenchymal cells (By similarity). May also regulate expression of Wnt antagonists such as DKK2 and SFPR2 in the developing tooth mesenchyme (By similarity). Required for BMP4 expression in dental mesenchyme cells (By similarity). Also, in response to BMP4, required for BMP4 expression in neighboring dental epithelial cells (By similarity). Required for maximal FGF4-induced expression of SDC1 in dental mesenchyme cells (By similarity). Also in response to SDC1, required for SDC1 expression in neighboring dental epithelial cells (By similarity). At the early bell stage, acts to drive proliferation of dental mesenchyme cells, however during the late bell stage acts as an homeostatic regulator of the cell cycle (By similarity). Regulates proliferation and inhibits premature mesenchymal odontogenesis during the bell stage via inhibition of the Wnt signaling component CTNNB1 and subsequent repression of the odontoblast differentiation factors BMP2, BMP4, LEF1, ALPL and BGLAP/OCN (By similarity). Additionally, required for correct development and fusion of the palatal shelves and embryonic mandibular formation (By similarity). Plays a role in embryonic bone formation of the middle ear, skull and nasal bones (By similarity). Required for correct formation and thickness of the nail plate (By similarity). May play a role in limb-pattern formation (By similarity). {ECO:0000250|UniProtKB:P13297, ECO:0000269|PubMed:12807959, ECO:0000303|PubMed:8696335}. |
P33991 | MCM4 | S32 | ochoa|psp | DNA replication licensing factor MCM4 (EC 3.6.4.12) (CDC21 homolog) (P1-CDC21) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:16899510, PubMed:25661590, PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232, PubMed:9305914). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:16899510, PubMed:25661590, PubMed:32453425, PubMed:9305914). {ECO:0000269|PubMed:16899510, ECO:0000269|PubMed:25661590, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:9305914}. |
P49450 | CENPA | T23 | ochoa|psp | Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A) | Histone H3-like nucleosomal protein that is specifically found in centromeric nucleosomes (PubMed:11756469, PubMed:14667408, PubMed:15282608, PubMed:15475964, PubMed:15702419, PubMed:17651496, PubMed:19114591, PubMed:20739937, PubMed:27499292, PubMed:7962047, PubMed:9024683). Replaces conventional H3 in the nucleosome core of centromeric chromatin that serves as an assembly site for the inner kinetochore (PubMed:18072184). The presence of CENPA subtly modifies the nucleosome structure and the way DNA is wrapped around the nucleosome and gives rise to protruding DNA ends that are less well-ordered and rigid compared to nucleosomes containing histone H3 (PubMed:26878239, PubMed:27499292). May serve as an epigenetic mark that propagates centromere identity through replication and cell division (PubMed:15282608, PubMed:15475964, PubMed:20739937, PubMed:21478274, PubMed:26878239). Required for recruitment and assembly of kinetochore proteins, and as a consequence required for progress through mitosis, chromosome segregation and cytokinesis (PubMed:11756469, PubMed:14667408, PubMed:18072184, PubMed:23818633, PubMed:25556658, PubMed:27499292). {ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:15475964, ECO:0000269|PubMed:15702419, ECO:0000269|PubMed:17651496, ECO:0000269|PubMed:18072184, ECO:0000269|PubMed:19114591, ECO:0000269|PubMed:21478274, ECO:0000269|PubMed:23818633, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26878239, ECO:0000269|PubMed:27499292, ECO:0000269|PubMed:7962047, ECO:0000269|PubMed:9024683, ECO:0000305|PubMed:20739937}. |
P49450 | CENPA | S37 | ochoa | Histone H3-like centromeric protein A (Centromere autoantigen A) (Centromere protein A) (CENP-A) | Histone H3-like nucleosomal protein that is specifically found in centromeric nucleosomes (PubMed:11756469, PubMed:14667408, PubMed:15282608, PubMed:15475964, PubMed:15702419, PubMed:17651496, PubMed:19114591, PubMed:20739937, PubMed:27499292, PubMed:7962047, PubMed:9024683). Replaces conventional H3 in the nucleosome core of centromeric chromatin that serves as an assembly site for the inner kinetochore (PubMed:18072184). The presence of CENPA subtly modifies the nucleosome structure and the way DNA is wrapped around the nucleosome and gives rise to protruding DNA ends that are less well-ordered and rigid compared to nucleosomes containing histone H3 (PubMed:26878239, PubMed:27499292). May serve as an epigenetic mark that propagates centromere identity through replication and cell division (PubMed:15282608, PubMed:15475964, PubMed:20739937, PubMed:21478274, PubMed:26878239). Required for recruitment and assembly of kinetochore proteins, and as a consequence required for progress through mitosis, chromosome segregation and cytokinesis (PubMed:11756469, PubMed:14667408, PubMed:18072184, PubMed:23818633, PubMed:25556658, PubMed:27499292). {ECO:0000269|PubMed:11756469, ECO:0000269|PubMed:14667408, ECO:0000269|PubMed:15282608, ECO:0000269|PubMed:15475964, ECO:0000269|PubMed:15702419, ECO:0000269|PubMed:17651496, ECO:0000269|PubMed:18072184, ECO:0000269|PubMed:19114591, ECO:0000269|PubMed:21478274, ECO:0000269|PubMed:23818633, ECO:0000269|PubMed:25556658, ECO:0000269|PubMed:26878239, ECO:0000269|PubMed:27499292, ECO:0000269|PubMed:7962047, ECO:0000269|PubMed:9024683, ECO:0000305|PubMed:20739937}. |
P49736 | MCM2 | S27 | ochoa|psp | DNA replication licensing factor MCM2 (EC 3.6.4.12) (Minichromosome maintenance protein 2 homolog) (Nuclear protein BM28) | Acts as a component of the MCM2-7 complex (MCM complex) which is the replicative helicase essential for 'once per cell cycle' DNA replication initiation and elongation in eukaryotic cells. Core component of CDC45-MCM-GINS (CMG) helicase, the molecular machine that unwinds template DNA during replication, and around which the replisome is built (PubMed:32453425, PubMed:34694004, PubMed:34700328, PubMed:35585232). The active ATPase sites in the MCM2-7 ring are formed through the interaction surfaces of two neighboring subunits such that a critical structure of a conserved arginine finger motif is provided in trans relative to the ATP-binding site of the Walker A box of the adjacent subunit. The six ATPase active sites, however, are likely to contribute differentially to the complex helicase activity (PubMed:32453425). Required for the entry in S phase and for cell division (PubMed:8175912). Plays a role in terminally differentiated hair cells development of the cochlea and induces cells apoptosis (PubMed:26196677). {ECO:0000269|PubMed:26196677, ECO:0000269|PubMed:32453425, ECO:0000269|PubMed:34694004, ECO:0000269|PubMed:34700328, ECO:0000269|PubMed:35585232, ECO:0000269|PubMed:8175912}. |
Q01130 | SRSF2 | S121 | psp | Serine/arginine-rich splicing factor 2 (Protein PR264) (Splicing component, 35 kDa) (Splicing factor SC35) (SC-35) (Splicing factor, arginine/serine-rich 2) | Necessary for the splicing of pre-mRNA. It is required for formation of the earliest ATP-dependent splicing complex and interacts with spliceosomal components bound to both the 5'- and 3'-splice sites during spliceosome assembly. It also is required for ATP-dependent interactions of both U1 and U2 snRNPs with pre-mRNA. Interacts with other spliceosomal components, via the RS domains, to form a bridge between the 5'- and 3'-splice site binding components, U1 snRNP and U2AF. Binds to purine-rich RNA sequences, either 5'-AGSAGAGTA-3' (S=C or G) or 5'-GTTCGAGTA-3'. Can bind to beta-globin mRNA and commit it to the splicing pathway. The phosphorylated form (by SRPK2) is required for cellular apoptosis in response to cisplatin treatment. {ECO:0000269|PubMed:19592491, ECO:0000269|PubMed:21157427}. |
Q07157 | TJP1 | S168 | psp | Tight junction protein 1 (Tight junction protein ZO-1) (Zona occludens protein 1) (Zonula occludens protein 1) | TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed:7798316, PubMed:9792688). Forms a multistranded TJP1/ZO1 condensate which elongates to form a tight junction belt, the belt is anchored at the apical cell membrane via interaction with PATJ (By similarity). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Necessary for lumenogenesis, and particularly efficient epithelial polarization and barrier formation (By similarity). Plays a role in the regulation of cell migration by targeting CDC42BPB to the leading edge of migrating cells (PubMed:21240187). Plays an important role in podosome formation and associated function, thus regulating cell adhesion and matrix remodeling (PubMed:20930113). With TJP2 and TJP3, participates in the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). May play a role in mediating cell morphology changes during ameloblast differentiation via its role in tight junctions (By similarity). {ECO:0000250|UniProtKB:O97758, ECO:0000250|UniProtKB:P39447, ECO:0000269|PubMed:20930113, ECO:0000269|PubMed:21240187}. |
Q07157 | TJP1 | S329 | ochoa | Tight junction protein 1 (Tight junction protein ZO-1) (Zona occludens protein 1) (Zonula occludens protein 1) | TJP1, TJP2, and TJP3 are closely related scaffolding proteins that link tight junction (TJ) transmembrane proteins such as claudins, junctional adhesion molecules, and occludin to the actin cytoskeleton (PubMed:7798316, PubMed:9792688). Forms a multistranded TJP1/ZO1 condensate which elongates to form a tight junction belt, the belt is anchored at the apical cell membrane via interaction with PATJ (By similarity). The tight junction acts to limit movement of substances through the paracellular space and as a boundary between the compositionally distinct apical and basolateral plasma membrane domains of epithelial and endothelial cells. Necessary for lumenogenesis, and particularly efficient epithelial polarization and barrier formation (By similarity). Plays a role in the regulation of cell migration by targeting CDC42BPB to the leading edge of migrating cells (PubMed:21240187). Plays an important role in podosome formation and associated function, thus regulating cell adhesion and matrix remodeling (PubMed:20930113). With TJP2 and TJP3, participates in the junctional retention and stability of the transcription factor DBPA, but is not involved in its shuttling to the nucleus (By similarity). May play a role in mediating cell morphology changes during ameloblast differentiation via its role in tight junctions (By similarity). {ECO:0000250|UniProtKB:O97758, ECO:0000250|UniProtKB:P39447, ECO:0000269|PubMed:20930113, ECO:0000269|PubMed:21240187}. |
Q13077 | TRAF1 | S66 | ochoa | TNF receptor-associated factor 1 (Epstein-Barr virus-induced protein 6) | Adapter molecule that regulates the activation of NF-kappa-B and JNK. Plays a role in the regulation of cell survival and apoptosis. The heterotrimer formed by TRAF1 and TRAF2 is part of a E3 ubiquitin-protein ligase complex that promotes ubiquitination of target proteins, such as MAP3K14. The TRAF1/TRAF2 complex recruits the antiapoptotic E3 protein-ubiquitin ligases BIRC2 and BIRC3 to TNFRSF1B/TNFR2. {ECO:0000269|PubMed:10692572, ECO:0000269|PubMed:16323247, ECO:0000269|PubMed:18429822, ECO:0000269|PubMed:19287455, ECO:0000269|PubMed:19698991, ECO:0000269|PubMed:20385093}. |
Q13233 | MAP3K1 | S266 | ochoa | Mitogen-activated protein kinase kinase kinase 1 (EC 2.7.11.25) (MAPK/ERK kinase kinase 1) (MEK kinase 1) (MEKK 1) (EC 2.3.2.27) | Component of a protein kinase signal transduction cascade (PubMed:9808624). Activates the ERK and JNK kinase pathways by phosphorylation of MAP2K1 and MAP2K4 (PubMed:9808624). May phosphorylate the MAPK8/JNK1 kinase (PubMed:17761173). Activates CHUK and IKBKB, the central protein kinases of the NF-kappa-B pathway (PubMed:9808624). {ECO:0000269|PubMed:17761173, ECO:0000269|PubMed:9808624}. |
Q14004 | CDK13 | S348 | ochoa | Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) | Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. {ECO:0000269|PubMed:16721827, ECO:0000269|PubMed:1731328, ECO:0000269|PubMed:18480452, ECO:0000269|PubMed:20952539}. |
Q14498 | RBM39 | S117 | ochoa | RNA-binding protein 39 (CAPER alpha) (CAPERalpha) (Hepatocellular carcinoma protein 1) (RNA-binding motif protein 39) (RNA-binding region-containing protein 2) (Splicing factor HCC1) | RNA-binding protein that acts as a pre-mRNA splicing factor (PubMed:15694343, PubMed:24795046, PubMed:28302793, PubMed:28437394, PubMed:31271494). Acts by promoting exon inclusion via regulation of exon cassette splicing (PubMed:31271494). Also acts as a transcriptional coactivator for steroid nuclear receptors ESR1/ER-alpha and ESR2/ER-beta, and JUN/AP-1, independently of the pre-mRNA splicing factor activity (By similarity). {ECO:0000250|UniProtKB:Q8VH51, ECO:0000269|PubMed:15694343, ECO:0000269|PubMed:24795046, ECO:0000269|PubMed:28302793, ECO:0000269|PubMed:28437394, ECO:0000269|PubMed:31271494}. |
Q15287 | RNPS1 | S266 | ochoa | RNA-binding protein with serine-rich domain 1 (SR-related protein LDC2) | Part of pre- and post-splicing multiprotein mRNP complexes. Auxiliary component of the splicing-dependent multiprotein exon junction complex (EJC) deposited at splice junction on mRNAs. The EJC is a dynamic structure consisting of core proteins and several peripheral nuclear and cytoplasmic associated factors that join the complex only transiently either during EJC assembly or during subsequent mRNA metabolism. Component of the ASAP and PSAP complexes which bind RNA in a sequence-independent manner and are proposed to be recruited to the EJC prior to or during the splicing process and to regulate specific excision of introns in specific transcription subsets. The ASAP complex can inhibit RNA processing during in vitro splicing reactions. The ASAP complex promotes apoptosis and is disassembled after induction of apoptosis. Enhances the formation of the ATP-dependent A complex of the spliceosome. Involved in both constitutive splicing and, in association with SRP54 and TRA2B/SFRS10, in distinctive modulation of alternative splicing in a substrate-dependent manner. Involved in the splicing modulation of BCL2L1/Bcl-X (and probably other apoptotic genes); specifically inhibits formation of proapoptotic isoforms such as Bcl-X(S); the activity is different from the established EJC assembly and function. Participates in mRNA 3'-end cleavage. Involved in UPF2-dependent nonsense-mediated decay (NMD) of mRNAs containing premature stop codons. Also mediates increase of mRNA abundance and translational efficiency. Binds spliced mRNA 20-25 nt upstream of exon-exon junctions. {ECO:0000269|PubMed:10449421, ECO:0000269|PubMed:11546874, ECO:0000269|PubMed:12665594, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:14729963, ECO:0000269|PubMed:14752011, ECO:0000269|PubMed:15684395, ECO:0000269|PubMed:16209946, ECO:0000269|PubMed:17586820, ECO:0000269|PubMed:22203037}. |
Q15735 | INPP5J | S902 | ochoa | Phosphatidylinositol 4,5-bisphosphate 5-phosphatase A (EC 3.1.3.36) (Inositol polyphosphate 5-phosphatase J) (Phosphatidylinositol 1,3,4,5-tetrakisphosphate 5-phosphatase) (EC 3.1.3.56) (Phosphatidylinositol 1,4,5-trisphosphate 5-phosphatase) (EC 3.1.3.56) | Inositol 5-phosphatase, which converts inositol 1,4,5-trisphosphate to inositol 1,4-bisphosphate. Also converts phosphatidylinositol 4,5-bisphosphate to phosphatidylinositol 4-phosphate and inositol 1,3,4,5-tetrakisphosphate to inositol 1,3,4-trisphosphate in vitro. May be involved in modulation of the function of inositol and phosphatidylinositol polyphosphate-binding proteins that are present at membranes ruffles. {ECO:0000250|UniProtKB:Q9JMC1}. |
Q15853 | USF2 | T230 | psp | Upstream stimulatory factor 2 (Class B basic helix-loop-helix protein 12) (bHLHb12) (FOS-interacting protein) (FIP) (Major late transcription factor 2) (Upstream transcription factor 2) | Transcription factor that binds to a symmetrical DNA sequence (E-boxes) (5'-CACGTG-3') that is found in a variety of viral and cellular promoters. |
Q3KQU3 | MAP7D1 | S460 | ochoa | MAP7 domain-containing protein 1 (Arginine/proline-rich coiled-coil domain-containing protein 1) (Proline/arginine-rich coiled-coil domain-containing protein 1) | Microtubule-stabilizing protein involved in the control of cell motility and neurite outgrowth. Facilitate microtubule stabilization through the maintenance of acetylated stable microtubules. {ECO:0000250|UniProtKB:A2AJI0}. |
Q5FWE3 | PRRT3 | S808 | ochoa | Proline-rich transmembrane protein 3 | None |
Q5SQI0 | ATAT1 | S315 | ochoa|psp | Alpha-tubulin N-acetyltransferase 1 (Alpha-TAT) (Alpha-TAT1) (TAT) (EC 2.3.1.108) (Acetyltransferase mec-17 homolog) | Specifically acetylates 'Lys-40' in alpha-tubulin on the lumenal side of microtubules. Promotes microtubule destabilization and accelerates microtubule dynamics; this activity may be independent of acetylation activity. Acetylates alpha-tubulin with a slow enzymatic rate, due to a catalytic site that is not optimized for acetyl transfer. Enters the microtubule through each end and diffuses quickly throughout the lumen of microtubules. Acetylates only long/old microtubules because of its slow acetylation rate since it does not have time to act on dynamically unstable microtubules before the enzyme is released. Required for normal sperm flagellar function. Promotes directional cell locomotion and chemotaxis, through AP2A2-dependent acetylation of alpha-tubulin at clathrin-coated pits that are concentrated at the leading edge of migrating cells. May facilitate primary cilium assembly. {ECO:0000255|HAMAP-Rule:MF_03130, ECO:0000269|PubMed:20829795, ECO:0000269|PubMed:21068373, ECO:0000269|PubMed:24097348, ECO:0000269|PubMed:24906155}. |
Q5T200 | ZC3H13 | S346 | ochoa | Zinc finger CCCH domain-containing protein 13 | Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (PubMed:29507755). Acts as a key regulator of m6A methylation by promoting m6A methylation of mRNAs at the 3'-UTR (By similarity). Controls embryonic stem cells (ESCs) pluripotency via its role in m6A methylation (By similarity). In the WMM complex, anchors component of the MACOM subcomplex in the nucleus (By similarity). Also required for bridging WTAP to the RNA-binding component RBM15 (RBM15 or RBM15B) (By similarity). {ECO:0000250|UniProtKB:E9Q784}. |
Q5VUA4 | ZNF318 | S81 | ochoa | Zinc finger protein 318 (Endocrine regulatory protein) | [Isoform 2]: Acts as a transcriptional corepressor for AR-mediated transactivation function. May act as a transcriptional regulator during spermatogenesis and, in particular, during meiotic division. {ECO:0000250|UniProtKB:Q99PP2}.; FUNCTION: [Isoform 1]: Acts as a transcriptional coactivator for AR-mediated transactivation function. May act as a transcriptional regulator during spermatogenesis and, in particular, during meiotic division. {ECO:0000250|UniProtKB:Q99PP2}. |
Q68DK2 | ZFYVE26 | S1780 | ochoa | Zinc finger FYVE domain-containing protein 26 (FYVE domain-containing centrosomal protein) (FYVE-CENT) (Spastizin) | Phosphatidylinositol 3-phosphate-binding protein required for the abscission step in cytokinesis: recruited to the midbody during cytokinesis and acts as a regulator of abscission. May also be required for efficient homologous recombination DNA double-strand break repair. {ECO:0000269|PubMed:20208530}. |
Q6ICG6 | KIAA0930 | S279 | ochoa | Uncharacterized protein KIAA0930 | None |
Q6IQ23 | PLEKHA7 | S612 | ochoa | Pleckstrin homology domain-containing family A member 7 (PH domain-containing family A member 7) | Required for zonula adherens biogenesis and maintenance (PubMed:19041755). Acts via its interaction with CAMSAP3, which anchors microtubules at their minus-ends to zonula adherens, leading to the recruitment of KIFC3 kinesin to the junctional site (PubMed:19041755). Mediates docking of ADAM10 to zonula adherens through a PDZD11-dependent interaction with the ADAM10-binding protein TSPAN33 (PubMed:30463011). {ECO:0000269|PubMed:19041755, ECO:0000269|PubMed:30463011}. |
Q6RI45 | BRWD3 | S693 | ochoa | Bromodomain and WD repeat-containing protein 3 | Plays a role in the regulation of cell morphology and cytoskeletal organization. Required in the control of cell shape. {ECO:0000269|PubMed:21834987}. |
Q6ZRV2 | FAM83H | S906 | ochoa | Protein FAM83H | May play a major role in the structural organization and calcification of developing enamel (PubMed:18252228). May play a role in keratin cytoskeleton disassembly by recruiting CSNK1A1 to keratin filaments. Thereby, it may regulate epithelial cell migration (PubMed:23902688). {ECO:0000269|PubMed:18252228, ECO:0000269|PubMed:23902688}. |
Q7KZI7 | MARK2 | S390 | ochoa | Serine/threonine-protein kinase MARK2 (EC 2.7.11.1) (EC 2.7.11.26) (ELKL motif kinase 1) (EMK-1) (MAP/microtubule affinity-regulating kinase 2) (PAR1 homolog) (PAR1 homolog b) (Par-1b) (Par1b) | Serine/threonine-protein kinase (PubMed:23666762). Involved in cell polarity and microtubule dynamics regulation. Phosphorylates CRTC2/TORC2, DCX, HDAC7, KIF13B, MAP2, MAP4 and RAB11FIP2. Phosphorylates the microtubule-associated protein MAPT/TAU (PubMed:23666762). Plays a key role in cell polarity by phosphorylating the microtubule-associated proteins MAP2, MAP4 and MAPT/TAU at KXGS motifs, causing detachment from microtubules, and their disassembly. Regulates epithelial cell polarity by phosphorylating RAB11FIP2. Involved in the regulation of neuronal migration through its dual activities in regulating cellular polarity and microtubule dynamics, possibly by phosphorylating and regulating DCX. Regulates axogenesis by phosphorylating KIF13B, promoting interaction between KIF13B and 14-3-3 and inhibiting microtubule-dependent accumulation of KIF13B. Also required for neurite outgrowth and establishment of neuronal polarity. Regulates localization and activity of some histone deacetylases by mediating phosphorylation of HDAC7, promoting subsequent interaction between HDAC7 and 14-3-3 and export from the nucleus. Also acts as a positive regulator of the Wnt signaling pathway, probably by mediating phosphorylation of dishevelled proteins (DVL1, DVL2 and/or DVL3). Modulates the developmental decision to build a columnar versus a hepatic epithelial cell apparently by promoting a switch from a direct to a transcytotic mode of apical protein delivery. Essential for the asymmetric development of membrane domains of polarized epithelial cells. {ECO:0000269|PubMed:11433294, ECO:0000269|PubMed:12429843, ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:15158914, ECO:0000269|PubMed:15324659, ECO:0000269|PubMed:15365179, ECO:0000269|PubMed:16775013, ECO:0000269|PubMed:16980613, ECO:0000269|PubMed:18626018, ECO:0000269|PubMed:20194617, ECO:0000269|PubMed:23666762}. |
Q7L4I2 | RSRC2 | S222 | ochoa | Arginine/serine-rich coiled-coil protein 2 | None |
Q7Z4K8 | TRIM46 | S88 | ochoa | Tripartite motif-containing protein 46 (Gene Y protein) (GeneY) (Tripartite, fibronectin type-III and C-terminal SPRY motif protein) | Microtubule-associated protein that is involved in the formation of parallel microtubule bundles linked by cross-bridges in the proximal axon. Required for the uniform orientation and maintenance of the parallel microtubule fascicles, which are important for efficient cargo delivery and trafficking in axons. Thereby also required for proper axon specification, the establishment of neuronal polarity and proper neuronal migration. {ECO:0000250|UniProtKB:Q7TNM2}. |
Q7Z6E9 | RBBP6 | S873 | ochoa | E3 ubiquitin-protein ligase RBBP6 (EC 2.3.2.27) (Proliferation potential-related protein) (Protein P2P-R) (RING-type E3 ubiquitin transferase RBBP6) (Retinoblastoma-binding Q protein 1) (RBQ-1) (Retinoblastoma-binding protein 6) (p53-associated cellular protein of testis) | E3 ubiquitin-protein ligase which promotes ubiquitination of YBX1, leading to its degradation by the proteasome (PubMed:18851979). May play a role as a scaffold protein to promote the assembly of the p53/TP53-MDM2 complex, resulting in increase of MDM2-mediated ubiquitination and degradation of p53/TP53; may function as negative regulator of p53/TP53, leading to both apoptosis and cell growth (By similarity). Regulates DNA-replication and the stability of chromosomal common fragile sites (CFSs) in a ZBTB38- and MCM10-dependent manner. Controls ZBTB38 protein stability and abundance via ubiquitination and proteasomal degradation, and ZBTB38 in turn negatively regulates the expression of MCM10 which plays an important role in DNA-replication (PubMed:24726359). {ECO:0000250|UniProtKB:P97868, ECO:0000269|PubMed:18851979, ECO:0000269|PubMed:24726359}.; FUNCTION: (Microbial infection) [Isoform 1]: Restricts ebolavirus replication probably by impairing the vp30-NP interaction, and thus viral transcription. {ECO:0000269|PubMed:30550789}. |
Q86VM9 | ZC3H18 | S842 | ochoa | Zinc finger CCCH domain-containing protein 18 (Nuclear protein NHN1) | None |
Q86XF7 | ZNF575 | S49 | ochoa | Zinc finger protein 575 | May be involved in transcriptional regulation. |
Q8IVT2 | MISP | S400 | ochoa|psp | Mitotic interactor and substrate of PLK1 (Mitotic spindle positioning protein) | Plays a role in mitotic spindle orientation and mitotic progression. Regulates the distribution of dynactin at the cell cortex in a PLK1-dependent manner, thus stabilizing cortical and astral microtubule attachments required for proper mitotic spindle positioning. May link microtubules to the actin cytospkeleton and focal adhesions. May be required for directed cell migration and centrosome orientation. May also be necessary for proper stacking of the Golgi apparatus. {ECO:0000269|PubMed:23509069, ECO:0000269|PubMed:23574715}. |
Q8IXT5 | RBM12B | S710 | ochoa | RNA-binding protein 12B (RNA-binding motif protein 12B) | None |
Q8IXT5 | RBM12B | S718 | ochoa | RNA-binding protein 12B (RNA-binding motif protein 12B) | None |
Q8IY33 | MICALL2 | S660 | ochoa | MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) | Effector of small Rab GTPases which is involved in junctional complexes assembly through the regulation of cell adhesion molecules transport to the plasma membrane and actin cytoskeleton reorganization. Regulates the endocytic recycling of occludins, claudins and E-cadherin to the plasma membrane and may thereby regulate the establishment of tight junctions and adherens junctions. In parallel, may regulate actin cytoskeleton reorganization directly through interaction with F-actin or indirectly through actinins and filamins. Most probably involved in the processes of epithelial cell differentiation, cell spreading and neurite outgrowth (By similarity). Undergoes liquid-liquid phase separation to form tubular recycling endosomes. Plays 2 sequential roles in the biogenesis of tubular recycling endosomes: first organizes phase separation and then the closed form formed by interaction with RAB8A promotes endosomal tubulation (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q3TN34}. |
Q8IYB3 | SRRM1 | S393 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | T406 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | T574 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | S597 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | S607 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | S628 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | S665 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | S675 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | S696 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8N3V7 | SYNPO | S525 | ochoa | Synaptopodin | Actin-associated protein that may play a role in modulating actin-based shape and motility of dendritic spines and renal podocyte foot processes. Seems to be essential for the formation of spine apparatuses in spines of telencephalic neurons, which is involved in synaptic plasticity (By similarity). {ECO:0000250}. |
Q8N3V7 | SYNPO | S536 | ochoa | Synaptopodin | Actin-associated protein that may play a role in modulating actin-based shape and motility of dendritic spines and renal podocyte foot processes. Seems to be essential for the formation of spine apparatuses in spines of telencephalic neurons, which is involved in synaptic plasticity (By similarity). {ECO:0000250}. |
Q8N3V7 | SYNPO | S548 | ochoa | Synaptopodin | Actin-associated protein that may play a role in modulating actin-based shape and motility of dendritic spines and renal podocyte foot processes. Seems to be essential for the formation of spine apparatuses in spines of telencephalic neurons, which is involved in synaptic plasticity (By similarity). {ECO:0000250}. |
Q8N8S7 | ENAH | S508 | ochoa | Protein enabled homolog | Ena/VASP proteins are actin-associated proteins involved in a range of processes dependent on cytoskeleton remodeling and cell polarity such as axon guidance and lamellipodial and filopodial dynamics in migrating cells. ENAH induces the formation of F-actin rich outgrowths in fibroblasts. Acts synergistically with BAIAP2-alpha and downstream of NTN1 to promote filipodia formation (By similarity). {ECO:0000250, ECO:0000269|PubMed:11696321, ECO:0000269|PubMed:18158903}. |
Q8NCF5 | NFATC2IP | S92 | ochoa | NFATC2-interacting protein (45 kDa NF-AT-interacting protein) (45 kDa NFAT-interacting protein) (Nuclear factor of activated T-cells, cytoplasmic 2-interacting protein) | In T-helper 2 (Th2) cells, regulates the magnitude of NFAT-driven transcription of a specific subset of cytokine genes, including IL3, IL4, IL5 and IL13, but not IL2. Recruits PRMT1 to the IL4 promoter; this leads to enhancement of histone H4 'Arg-3'-methylation and facilitates subsequent histone acetylation at the IL4 locus, thus promotes robust cytokine expression (By similarity). Down-regulates formation of poly-SUMO chains by UBE2I/UBC9 (By similarity). {ECO:0000250}. |
Q8WXE0 | CASKIN2 | S858 | ochoa | Caskin-2 (CASK-interacting protein 2) | None |
Q92617 | NPIPB3 | S983 | ochoa | Nuclear pore complex-interacting protein family member B3 (Nuclear pore complex-interacting protein-like 3) (Protein pps22-1) | None |
Q96F86 | EDC3 | S152 | ochoa | Enhancer of mRNA-decapping protein 3 (LSM16 homolog) (YjeF N-terminal domain-containing protein 2) (YjeF_N2) (hYjeF_N2) (YjeF domain-containing protein 1) | Binds single-stranded RNA. Involved in the process of mRNA degradation and in the positive regulation of mRNA decapping. May play a role in spermiogenesis and oogenesis. {ECO:0000269|PubMed:16364915, ECO:0000269|PubMed:17533573, ECO:0000269|PubMed:18678652, ECO:0000269|PubMed:25701870}. |
Q96HA1 | POM121 | S188 | ochoa | Nuclear envelope pore membrane protein POM 121 (Nuclear envelope pore membrane protein POM 121A) (Nucleoporin Nup121) (Pore membrane protein of 121 kDa) | Essential component of the nuclear pore complex (NPC). The repeat-containing domain may be involved in anchoring components of the pore complex to the pore membrane. When overexpressed in cells induces the formation of cytoplasmic annulate lamellae (AL). {ECO:0000269|PubMed:17900573}. |
Q96JP5 | ZFP91 | S296 | ochoa | E3 ubiquitin-protein ligase ZFP91 (EC 2.3.2.27) (RING-type E3 ubiquitin transferase ZFP91) (Zinc finger protein 757) (Zinc finger protein 91 homolog) (Zfp-91) | Atypical E3 ubiquitin-protein ligase that mediates 'Lys-63'-linked ubiquitination of MAP3K14/NIK, leading to stabilize and activate MAP3K14/NIK. It thereby acts as an activator of the non-canonical NF-kappa-B2/NFKB2 pathway. May also play an important role in cell proliferation and/or anti-apoptosis. {ECO:0000269|PubMed:12738986, ECO:0000269|PubMed:20682767}. |
Q96NA8 | TSNARE1 | S96 | ochoa | t-SNARE domain-containing protein 1 | None |
Q96T37 | RBM15 | S700 | ochoa | RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15) | RNA-binding protein that acts as a key regulator of N6-methyladenosine (m6A) methylation of RNAs, thereby regulating different processes, such as hematopoietic cell homeostasis, alternative splicing of mRNAs and X chromosome inactivation mediated by Xist RNA (PubMed:27602518). Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (By similarity). Plays a key role in m6A methylation, possibly by binding target RNAs and recruiting the WMM complex (PubMed:27602518). Involved in random X inactivation mediated by Xist RNA: acts by binding Xist RNA and recruiting the WMM complex, which mediates m6A methylation, leading to target YTHDC1 reader on Xist RNA and promoting transcription repression activity of Xist (PubMed:27602518). Required for the development of multiple tissues, such as the maintenance of the homeostasis of long-term hematopoietic stem cells and for megakaryocyte (MK) and B-cell differentiation (By similarity). Regulates megakaryocyte differentiation by regulating alternative splicing of genes important for megakaryocyte differentiation; probably regulates alternative splicing via m6A regulation (PubMed:26575292). Required for placental vascular branching morphogenesis and embryonic development of the heart and spleen (By similarity). Acts as a regulator of thrombopoietin response in hematopoietic stem cells by regulating alternative splicing of MPL (By similarity). May also function as an mRNA export factor, stimulating export and expression of RTE-containing mRNAs which are present in many retrotransposons that require to be exported prior to splicing (PubMed:17001072, PubMed:19786495). High affinity binding of pre-mRNA to RBM15 may allow targeting of the mRNP to the export helicase DBP5 in a manner that is independent of splicing-mediated NXF1 deposition, resulting in export prior to splicing (PubMed:17001072, PubMed:19786495). May be implicated in HOX gene regulation (PubMed:11344311). {ECO:0000250|UniProtKB:Q0VBL3, ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:19786495, ECO:0000269|PubMed:26575292, ECO:0000269|PubMed:27602518, ECO:0000305|PubMed:11344311}. |
Q96T58 | SPEN | S727 | ochoa | Msx2-interacting protein (SMART/HDAC1-associated repressor protein) (SPEN homolog) | May serve as a nuclear matrix platform that organizes and integrates transcriptional responses. In osteoblasts, supports transcription activation: synergizes with RUNX2 to enhance FGFR2-mediated activation of the osteocalcin FGF-responsive element (OCFRE) (By similarity). Has also been shown to be an essential corepressor protein, which probably regulates different key pathways such as the Notch pathway. Negative regulator of the Notch pathway via its interaction with RBPSUH, which prevents the association between NOTCH1 and RBPSUH, and therefore suppresses the transactivation activity of Notch signaling. Blocks the differentiation of precursor B-cells into marginal zone B-cells. Probably represses transcription via the recruitment of large complexes containing histone deacetylase proteins. May bind both to DNA and RNA. {ECO:0000250|UniProtKB:Q62504, ECO:0000269|PubMed:11331609, ECO:0000269|PubMed:12374742}. |
Q99501 | GAS2L1 | S297 | ochoa | GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1) | Involved in the cross-linking of microtubules and microfilaments (PubMed:12584248, PubMed:24706950). Regulates microtubule dynamics and stability by interacting with microtubule plus-end tracking proteins, such as MAPRE1, to regulate microtubule growth along actin stress fibers (PubMed:24706950). {ECO:0000269|PubMed:12584248, ECO:0000269|PubMed:24706950}. |
Q99501 | GAS2L1 | S429 | ochoa | GAS2-like protein 1 (GAS2-related protein on chromosome 22) (Growth arrest-specific protein 2-like 1) | Involved in the cross-linking of microtubules and microfilaments (PubMed:12584248, PubMed:24706950). Regulates microtubule dynamics and stability by interacting with microtubule plus-end tracking proteins, such as MAPRE1, to regulate microtubule growth along actin stress fibers (PubMed:24706950). {ECO:0000269|PubMed:12584248, ECO:0000269|PubMed:24706950}. |
Q9BRD0 | BUD13 | S127 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S139 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S151 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S163 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S175 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S188 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S201 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S214 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S226 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BRD0 | BUD13 | S248 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BU76 | MMTAG2 | S235 | ochoa | Multiple myeloma tumor-associated protein 2 (hMMTAG2) | None |
Q9BWN1 | PRR14 | S513 | ochoa | Proline-rich protein 14 | Functions in tethering peripheral heterochromatin to the nuclear lamina during interphase, possibly through the interaction with heterochromatin protein CBX5/HP1 alpha (PubMed:24209742). Might play a role in reattaching heterochromatin to the nuclear lamina at mitotic exit (PubMed:24209742). Promotes myoblast differentiation during skeletal myogenesis, possibly by stimulating transcription factor MyoD activity via binding to CBX5/HP1 alpha (PubMed:25906157). Involved in the positive regulation of the PI3K-Akt-mTOR signaling pathway and in promoting cell proliferation, possibly via binding to GRB2 (PubMed:27041574). {ECO:0000269|PubMed:24209742, ECO:0000269|PubMed:25906157, ECO:0000269|PubMed:27041574}. |
Q9HCD5 | NCOA5 | S116 | ochoa | Nuclear receptor coactivator 5 (NCoA-5) (Coactivator independent of AF-2) (CIA) | Nuclear receptor coregulator that can have both coactivator and corepressor functions. Interacts with nuclear receptors for steroids (ESR1 and ESR2) independently of the steroid binding domain (AF-2) of the ESR receptors, and with the orphan nuclear receptor NR1D2. Involved in the coactivation of nuclear steroid receptors (ER) as well as the corepression of MYC in response to 17-beta-estradiol (E2). {ECO:0000269|PubMed:15073177}. |
Q9NYV4 | CDK12 | S291 | ochoa | Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) | Cyclin-dependent kinase that phosphorylates the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), thereby acting as a key regulator of transcription elongation. Regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability. Preferentially phosphorylates 'Ser-5' in CTD repeats that are already phosphorylated at 'Ser-7', but can also phosphorylate 'Ser-2'. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogen inhibitors. {ECO:0000269|PubMed:11683387, ECO:0000269|PubMed:19651820, ECO:0000269|PubMed:20952539, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:24662513}. |
Q9NYV4 | CDK12 | S293 | ochoa | Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) | Cyclin-dependent kinase that phosphorylates the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), thereby acting as a key regulator of transcription elongation. Regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability. Preferentially phosphorylates 'Ser-5' in CTD repeats that are already phosphorylated at 'Ser-7', but can also phosphorylate 'Ser-2'. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogen inhibitors. {ECO:0000269|PubMed:11683387, ECO:0000269|PubMed:19651820, ECO:0000269|PubMed:20952539, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:24662513}. |
Q9NYV4 | CDK12 | S325 | ochoa | Cyclin-dependent kinase 12 (EC 2.7.11.22) (EC 2.7.11.23) (Cdc2-related kinase, arginine/serine-rich) (CrkRS) (Cell division cycle 2-related protein kinase 7) (CDC2-related protein kinase 7) (Cell division protein kinase 12) (hCDK12) | Cyclin-dependent kinase that phosphorylates the C-terminal domain (CTD) of the large subunit of RNA polymerase II (POLR2A), thereby acting as a key regulator of transcription elongation. Regulates the expression of genes involved in DNA repair and is required for the maintenance of genomic stability. Preferentially phosphorylates 'Ser-5' in CTD repeats that are already phosphorylated at 'Ser-7', but can also phosphorylate 'Ser-2'. Required for RNA splicing, possibly by phosphorylating SRSF1/SF2. Involved in regulation of MAP kinase activity, possibly leading to affect the response to estrogen inhibitors. {ECO:0000269|PubMed:11683387, ECO:0000269|PubMed:19651820, ECO:0000269|PubMed:20952539, ECO:0000269|PubMed:22012619, ECO:0000269|PubMed:24662513}. |
Q9NYZ3 | GTSE1 | S520 | ochoa | G2 and S phase-expressed protein 1 (GTSE-1) (Protein B99 homolog) | May be involved in p53-induced cell cycle arrest in G2/M phase by interfering with microtubule rearrangements that are required to enter mitosis. Overexpression delays G2/M phase progression. |
Q9P227 | ARHGAP23 | S1393 | ochoa | Rho GTPase-activating protein 23 (Rho-type GTPase-activating protein 23) | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}. |
Q9P265 | DIP2B | S83 | ochoa | Disco-interacting protein 2 homolog B (DIP2 homolog B) | Negatively regulates axonal outgrowth and is essential for normal synaptic transmission. Not required for regulation of axon polarity. Promotes acetylation of alpha-tubulin. {ECO:0000250|UniProtKB:Q3UH60}. |
Q9P270 | SLAIN2 | S357 | ochoa | SLAIN motif-containing protein 2 | Binds to the plus end of microtubules and regulates microtubule dynamics and microtubule organization. Promotes cytoplasmic microtubule nucleation and elongation. Required for normal structure of the microtubule cytoskeleton during interphase. {ECO:0000269|PubMed:21646404}. |
Q9UIF9 | BAZ2A | S1770 | ochoa | Bromodomain adjacent to zinc finger domain protein 2A (Transcription termination factor I-interacting protein 5) (TTF-I-interacting protein 5) (Tip5) (hWALp3) | Regulatory subunit of the ATP-dependent NoRC-1 and NoRC-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template (PubMed:28801535). Directly stimulates the ATPase activity of SMARCA5 in the NoRC-5 ISWI chromatin remodeling complex (PubMed:28801535). The NoRC-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the NoRC-5 ISWI chromatin remodeling complex (PubMed:28801535). Within the NoRC-5 ISWI chromatin remodeling complex, mediates silencing of a fraction of rDNA by recruiting histone-modifying enzymes and DNA methyltransferases, leading to heterochromatin formation and transcriptional silencing (By similarity). In the complex, it plays a central role by being recruited to rDNA and by targeting chromatin modifying enzymes such as HDAC1, leading to repress RNA polymerase I transcription (By similarity). Recruited to rDNA via its interaction with TTF1 and its ability to recognize and bind histone H4 acetylated on 'Lys-16' (H4K16ac), leading to deacetylation of H4K5ac, H4K8ac, H4K12ac but not H4K16ac (By similarity). Specifically binds pRNAs, 150-250 nucleotide RNAs that are complementary in sequence to the rDNA promoter; pRNA-binding is required for heterochromatin formation and rDNA silencing (By similarity). {ECO:0000250|UniProtKB:Q91YE5, ECO:0000269|PubMed:28801535}. |
Q9UIS9 | MBD1 | S399 | ochoa | Methyl-CpG-binding domain protein 1 (CXXC-type zinc finger protein 3) (Methyl-CpG-binding protein MBD1) (Protein containing methyl-CpG-binding domain 1) | Transcriptional repressor that binds CpG islands in promoters where the DNA is methylated at position 5 of cytosine within CpG dinucleotides. Binding is abolished by the presence of 7-mG that is produced by DNA damage by methylmethanesulfonate (MMS). Acts as transcriptional repressor and plays a role in gene silencing by recruiting ATF7IP, which in turn recruits factors such as the histone methyltransferase SETDB1. Probably forms a complex with SETDB1 and ATF7IP that represses transcription and couples DNA methylation and histone 'Lys-9' trimethylation. Isoform 1 and isoform 2 can also repress transcription from unmethylated promoters. {ECO:0000269|PubMed:10454587, ECO:0000269|PubMed:10648624, ECO:0000269|PubMed:12665582, ECO:0000269|PubMed:12697822, ECO:0000269|PubMed:12711603, ECO:0000269|PubMed:14555760, ECO:0000269|PubMed:14610093, ECO:0000269|PubMed:9207790, ECO:0000269|PubMed:9774669}. |
Q9UKJ3 | GPATCH8 | S740 | ochoa | G patch domain-containing protein 8 | None |
Q9ULD2 | MTUS1 | S752 | ochoa | Microtubule-associated tumor suppressor 1 (AT2 receptor-binding protein) (Angiotensin-II type 2 receptor-interacting protein) (Mitochondrial tumor suppressor 1) | Cooperates with AGTR2 to inhibit ERK2 activation and cell proliferation. May be required for AGTR2 cell surface expression. Together with PTPN6, induces UBE2V2 expression upon angiotensin-II stimulation. Isoform 1 inhibits breast cancer cell proliferation, delays the progression of mitosis by prolonging metaphase and reduces tumor growth. {ECO:0000269|PubMed:12692079, ECO:0000269|PubMed:19794912}. |
Q9UQ35 | SRRM2 | S1857 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1869 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1893 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1916 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1975 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S1987 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S2692 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S2694 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | S2714 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9Y2U8 | LEMD3 | S185 | ochoa | Inner nuclear membrane protein Man1 (LEM domain-containing protein 3) | Can function as a specific repressor of TGF-beta, activin, and BMP signaling through its interaction with the R-SMAD proteins. Antagonizes TGF-beta-induced cell proliferation arrest. {ECO:0000269|PubMed:15601644, ECO:0000269|PubMed:15647271}. |
Q9NS23 | RASSF1 | S188 | SIGNOR | Ras association domain-containing protein 1 | Potential tumor suppressor. Required for death receptor-dependent apoptosis. Mediates activation of STK3/MST2 and STK4/MST1 during Fas-induced apoptosis by preventing their dephosphorylation. When associated with MOAP1, promotes BAX conformational change and translocation to mitochondrial membranes in response to TNF and TNFSF10 stimulation. Isoform A interacts with CDC20, an activator of the anaphase-promoting complex, APC, resulting in the inhibition of APC activity and mitotic progression. Inhibits proliferation by negatively regulating cell cycle progression at the level of G1/S-phase transition by regulating accumulation of cyclin D1 protein. Isoform C has been shown not to perform these roles, no function has been identified for this isoform. Isoform A disrupts interactions among MDM2, DAXX and USP7, thus contributing to the efficient activation of TP53 by promoting MDM2 self-ubiquitination in cell-cycle checkpoint control in response to DNA damage. {ECO:0000269|PubMed:10888881, ECO:0000269|PubMed:11333291, ECO:0000269|PubMed:12024041, ECO:0000269|PubMed:14743218, ECO:0000269|PubMed:15109305, ECO:0000269|PubMed:15949439, ECO:0000269|PubMed:16510573, ECO:0000269|PubMed:18566590, ECO:0000269|PubMed:21199877}. |
Q14204 | DYNC1H1 | S4162 | Sugiyama | Cytoplasmic dynein 1 heavy chain 1 (Cytoplasmic dynein heavy chain 1) (Dynein heavy chain, cytosolic) | Cytoplasmic dynein 1 acts as a motor for the intracellular retrograde motility of vesicles and organelles along microtubules. Dynein has ATPase activity; the force-producing power stroke is thought to occur on release of ADP. Plays a role in mitotic spindle assembly and metaphase plate congression (PubMed:27462074). {ECO:0000269|PubMed:27462074}. |
A6NHQ4 | EPOP | S36 | ochoa | Elongin BC and Polycomb repressive complex 2-associated protein (Proline-rich protein 28) | Scaffold protein that serves as a bridging partner between the PRC2/EZH2 complex and the elongin BC complex: required to fine-tune the transcriptional status of Polycomb group (PcG) target genes in embryonic stem cells (ESCs). Plays a key role in genomic regions that display both active and repressive chromatin properties in pluripotent stem cells by sustaining low level expression at PcG target genes: acts by recruiting the elongin BC complex, thereby restricting excessive activity of the PRC2/EZH2 complex. Interaction with USP7 promotes deubiquitination of H2B at promoter sites. Acts as a regulator of neuronal differentiation. {ECO:0000250|UniProtKB:Q7TNS8}. |
A6NHR9 | SMCHD1 | S1974 | ochoa | Structural maintenance of chromosomes flexible hinge domain-containing protein 1 (SMC hinge domain-containing protein 1) (EC 3.6.1.-) | Non-canonical member of the structural maintenance of chromosomes (SMC) protein family that plays a key role in epigenetic silencing by regulating chromatin architecture (By similarity). Promotes heterochromatin formation in both autosomes and chromosome X, probably by mediating the merge of chromatin compartments (By similarity). Plays a key role in chromosome X inactivation in females by promoting the spreading of heterochromatin (PubMed:23542155). Recruited to inactivated chromosome X by Xist RNA and acts by mediating the merge of chromatin compartments: promotes random chromatin interactions that span the boundaries of existing structures, leading to create a compartment-less architecture typical of inactivated chromosome X (By similarity). Required to facilitate Xist RNA spreading (By similarity). Also required for silencing of a subset of clustered autosomal loci in somatic cells, such as the DUX4 locus (PubMed:23143600). Has ATPase activity; may participate in structural manipulation of chromatin in an ATP-dependent manner as part of its role in gene expression regulation (PubMed:29748383). Also plays a role in DNA repair: localizes to sites of DNA double-strand breaks in response to DNA damage to promote the repair of DNA double-strand breaks (PubMed:24790221, PubMed:25294876). Acts by promoting non-homologous end joining (NHEJ) and inhibiting homologous recombination (HR) repair (PubMed:25294876). {ECO:0000250|UniProtKB:Q6P5D8, ECO:0000269|PubMed:23143600, ECO:0000269|PubMed:23542155, ECO:0000269|PubMed:24790221, ECO:0000269|PubMed:25294876, ECO:0000269|PubMed:29748383}. |
O43900 | PRICKLE3 | S491 | ochoa | Prickle planar cell polarity protein 3 (LIM domain only protein 6) (LMO-6) (Prickle-like protein 3) (Pk3) (Triple LIM domain protein 6) | Involved in the planar cell polarity (PCP) pathway that is essential for the polarization of epithelial cells during morphogenetic processes, including gastrulation and neurulation (By similarity). PCP is maintained by two molecular modules, the global and the core modules, PRICKLE3 being part of the core module (By similarity). Distinct complexes of the core module segregate to opposite sides of the cell, where they interact with the opposite complex in the neighboring cell at or near the adherents junctions (By similarity). Involved in the organization of the basal body (By similarity). Involved in cilia growth and positioning (By similarity). Required for proper assembly, stability, and function of mitochondrial membrane ATP synthase (mitochondrial complex V) (PubMed:32516135). {ECO:0000250|UniProtKB:A8WH69, ECO:0000269|PubMed:32516135}. |
O75420 | GIGYF1 | S230 | ochoa | GRB10-interacting GYF protein 1 (PERQ amino acid-rich with GYF domain-containing protein 1) | May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling. May increase IGF1 receptor phosphorylation under IGF1 stimulation as well as phosphorylation of IRS1 and SHC1 (By similarity). {ECO:0000250, ECO:0000269|PubMed:12771153}. |
O75676 | RPS6KA4 | S737 | ochoa | Ribosomal protein S6 kinase alpha-4 (S6K-alpha-4) (EC 2.7.11.1) (90 kDa ribosomal protein S6 kinase 4) (Nuclear mitogen- and stress-activated protein kinase 2) (Ribosomal protein kinase B) (RSKB) | Serine/threonine-protein kinase that is required for the mitogen or stress-induced phosphorylation of the transcription factors CREB1 and ATF1 and for the regulation of the transcription factor RELA, and that contributes to gene activation by histone phosphorylation and functions in the regulation of inflammatory genes. Phosphorylates CREB1 and ATF1 in response to mitogenic or stress stimuli such as UV-C irradiation, epidermal growth factor (EGF) and anisomycin. Plays an essential role in the control of RELA transcriptional activity in response to TNF. Phosphorylates 'Ser-10' of histone H3 in response to mitogenics, stress stimuli and EGF, which results in the transcriptional activation of several immediate early genes, including proto-oncogenes c-fos/FOS and c-jun/JUN. May also phosphorylate 'Ser-28' of histone H3. Mediates the mitogen- and stress-induced phosphorylation of high mobility group protein 1 (HMGN1/HMG14). In lipopolysaccharide-stimulated primary macrophages, acts downstream of the Toll-like receptor TLR4 to limit the production of pro-inflammatory cytokines. Functions probably by inducing transcription of the MAP kinase phosphatase DUSP1 and the anti-inflammatory cytokine interleukin 10 (IL10), via CREB1 and ATF1 transcription factors. {ECO:0000269|PubMed:11035004, ECO:0000269|PubMed:12773393, ECO:0000269|PubMed:9792677}. |
P18583 | SON | S966 | ochoa | Protein SON (Bax antagonist selected in saccharomyces 1) (BASS1) (Negative regulatory element-binding protein) (NRE-binding protein) (Protein DBP-5) (SON3) | RNA-binding protein that acts as a mRNA splicing cofactor by promoting efficient splicing of transcripts that possess weak splice sites. Specifically promotes splicing of many cell-cycle and DNA-repair transcripts that possess weak splice sites, such as TUBG1, KATNB1, TUBGCP2, AURKB, PCNT, AKT1, RAD23A, and FANCG. Probably acts by facilitating the interaction between Serine/arginine-rich proteins such as SRSF2 and the RNA polymerase II. Also binds to DNA; binds to the consensus DNA sequence: 5'-GA[GT]AN[CG][AG]CC-3'. May indirectly repress hepatitis B virus (HBV) core promoter activity and transcription of HBV genes and production of HBV virions. Essential for correct RNA splicing of multiple genes critical for brain development, neuronal migration and metabolism, including TUBG1, FLNA, PNKP, WDR62, PSMD3, PCK2, PFKL, IDH2, and ACY1 (PubMed:27545680). {ECO:0000269|PubMed:20581448, ECO:0000269|PubMed:21504830, ECO:0000269|PubMed:27545680}. |
P23588 | EIF4B | S183 | ochoa | Eukaryotic translation initiation factor 4B (eIF-4B) | Required for the binding of mRNA to ribosomes. Functions in close association with EIF4-F and EIF4-A. Binds near the 5'-terminal cap of mRNA in presence of EIF-4F and ATP. Promotes the ATPase activity and the ATP-dependent RNA unwinding activity of both EIF4-A and EIF4-F. |
P31629 | HIVEP2 | S2118 | ochoa|psp | Transcription factor HIVEP2 (Human immunodeficiency virus type I enhancer-binding protein 2) (HIV-EP2) (MHC-binding protein 2) (MBP-2) | This protein specifically binds to the DNA sequence 5'-GGGACTTTCC-3' which is found in the enhancer elements of numerous viral promoters such as those of SV40, CMV, or HIV1. In addition, related sequences are found in the enhancer elements of a number of cellular promoters, including those of the class I MHC, interleukin-2 receptor, somatostatin receptor II, and interferon-beta genes. It may act in T-cell activation. |
P54259 | ATN1 | S34 | ochoa | Atrophin-1 (Dentatorubral-pallidoluysian atrophy protein) | Transcriptional corepressor. Recruits NR2E1 to repress transcription. Promotes vascular smooth cell (VSMC) migration and orientation (By similarity). Corepressor of MTG8 transcriptional repression. Has some intrinsic repression activity which is independent of the number of poly-Gln (polyQ) repeats. {ECO:0000250|UniProtKB:O35126, ECO:0000269|PubMed:10085113, ECO:0000269|PubMed:10973986}. |
Q02040 | AKAP17A | S640 | ochoa | A-kinase anchor protein 17A (AKAP-17A) (721P) (B-lymphocyte antigen) (Protein XE7) (Protein kinase A-anchoring protein 17A) (PRKA17A) (Splicing factor, arginine/serine-rich 17A) | Splice factor regulating alternative splice site selection for certain mRNA precursors. Mediates regulation of pre-mRNA splicing in a PKA-dependent manner. {ECO:0000269|PubMed:16982639, ECO:0000269|PubMed:19840947}. |
Q08AD1 | CAMSAP2 | S1011 | ochoa | Calmodulin-regulated spectrin-associated protein 2 (Calmodulin-regulated spectrin-associated protein 1-like protein 1) | Key microtubule-organizing protein that specifically binds the minus-end of non-centrosomal microtubules and regulates their dynamics and organization (PubMed:23169647, PubMed:24486153, PubMed:24706919). Specifically recognizes growing microtubule minus-ends and autonomously decorates and stabilizes microtubule lattice formed by microtubule minus-end polymerization (PubMed:24486153, PubMed:24706919). Acts on free microtubule minus-ends that are not capped by microtubule-nucleating proteins or other factors and protects microtubule minus-ends from depolymerization (PubMed:24486153, PubMed:24706919). In addition, it also reduces the velocity of microtubule polymerization (PubMed:24486153, PubMed:24706919). Through the microtubule cytoskeleton, also regulates the organization of cellular organelles including the Golgi and the early endosomes (PubMed:27666745). Essential for the tethering, but not for nucleation of non-centrosomal microtubules at the Golgi: together with Golgi-associated proteins AKAP9 and PDE4DIP, required to tether non-centrosomal minus-end microtubules to the Golgi, an important step for polarized cell movement (PubMed:27666745). Also acts as a regulator of neuronal polarity and development: localizes to non-centrosomal microtubule minus-ends in neurons and stabilizes non-centrosomal microtubules, which is required for neuronal polarity, axon specification and dendritic branch formation (PubMed:24908486). Through the microtubule cytoskeleton, regulates the autophagosome transport (PubMed:28726242). {ECO:0000269|PubMed:23169647, ECO:0000269|PubMed:24486153, ECO:0000269|PubMed:24706919, ECO:0000269|PubMed:24908486, ECO:0000269|PubMed:27666745, ECO:0000269|PubMed:28726242}. |
Q12968 | NFATC3 | S269 | ochoa | Nuclear factor of activated T-cells, cytoplasmic 3 (NF-ATc3) (NFATc3) (NFATx) (T-cell transcription factor NFAT4) (NF-AT4) (NF-AT4c) | Acts as a regulator of transcriptional activation. Binds to the TNFSF11/RANKL promoter region and promotes TNFSF11 transcription (By similarity). Binding to the TNFSF11 promoter region is increased by high levels of Ca(2+) which induce NFATC3 expression and may lead to regulation of TNFSF11 expression in osteoblasts (By similarity). Plays a role in promoting mesenteric arterial wall remodeling in response to the intermittent hypoxia-induced increase in EDN1 and ROCK signaling (By similarity). As a result NFATC3 colocalizes with F-actin filaments, translocates to the nucleus and promotes transcription of the smooth muscle hypertrophy and differentiation marker ACTA2 (By similarity). Promotes lipopolysaccharide-induced apoptosis and hypertrophy in cardiomyocytes (By similarity). Following JAK/STAT signaling activation and as part of a complex with NFATC4 and STAT3, binds to the alpha-beta E4 promoter region of CRYAB and activates transcription in cardiomyocytes (By similarity). In conjunction with NFATC4, involved in embryonic heart development via maintenance of cardiomyocyte survival, proliferation and differentiation (By similarity). Plays a role in the inducible expression of cytokine genes in T-cells, especially in the induction of the IL-2 (PubMed:18815128). Required for thymocyte maturation during DN3 to DN4 transition and during positive selection (By similarity). Positively regulates macrophage-derived polymicrobial clearance, via binding to the promoter region and promoting transcription of NOS2 resulting in subsequent generation of nitric oxide (By similarity). Involved in Ca(2+)-mediated transcriptional responses upon Ca(2+) influx via ORAI1 CRAC channels. {ECO:0000250|UniProtKB:A0A0G2JTY4, ECO:0000250|UniProtKB:P97305, ECO:0000269|PubMed:18815128, ECO:0000269|PubMed:32415068}. |
Q13136 | PPFIA1 | S693 | ochoa | Liprin-alpha-1 (LAR-interacting protein 1) (LIP-1) (Protein tyrosine phosphatase receptor type f polypeptide-interacting protein alpha-1) (PTPRF-interacting protein alpha-1) | May regulate the disassembly of focal adhesions. May localize receptor-like tyrosine phosphatases type 2A at specific sites on the plasma membrane, possibly regulating their interaction with the extracellular environment and their association with substrates. {ECO:0000269|PubMed:7796809}. |
Q13523 | PRP4K | S368 | ochoa | Serine/threonine-protein kinase PRP4 homolog (EC 2.7.11.1) (PRP4 kinase) (PRP4 pre-mRNA-processing factor 4 homolog) | Serine/threonine kinase involved in spliceosomal assembly as well as mitosis and signaling regulation (PubMed:10799319, PubMed:12077342, PubMed:17513757, PubMed:17998396). Connects chromatin mediated regulation of transcription and pre-mRNA splicing (PubMed:12077342). During spliceosomal assembly, interacts with and phosphorylates PRPF6 and PRPF31, components of the U4/U6-U5 tri-small nuclear ribonucleoprotein (snRNP), to facilitate the formation of the spliceosome B complex. Plays a role in regulating transcription and the spindle assembly checkpoint (SAC) (PubMed:20118938). Associates with U5 snRNP and NCOR1 deacetylase complexes which may allow a coordination of pre-mRNA splicing with chromatin remodeling events involved in transcriptional regulation (PubMed:12077342). Associates and probably phosphorylates SMARCA4 and NCOR1 (PubMed:12077342). Phosphorylates SRSF1 (PubMed:11418604). Associates with kinetochores during mitosis and is necessary for recruitment and maintenance of the checkpoint proteins such as MAD1L1 and MAD12L1 at the kinetochores (PubMed:17998396). Phosphorylates and regulates the activity of the transcription factors such as ELK1 and KLF13 (PubMed:10799319, PubMed:17513757). Phosphorylates nuclear YAP1 and WWTR1/TAZ which induces nuclear exclusion and regulates Hippo signaling pathway, involved in tissue growth control (PubMed:29695716). {ECO:0000269|PubMed:10799319, ECO:0000269|PubMed:11418604, ECO:0000269|PubMed:12077342, ECO:0000269|PubMed:17513757, ECO:0000269|PubMed:17998396, ECO:0000269|PubMed:20118938, ECO:0000269|PubMed:29695716}. |
Q14004 | CDK13 | S349 | ochoa | Cyclin-dependent kinase 13 (EC 2.7.11.22) (EC 2.7.11.23) (CDC2-related protein kinase 5) (Cell division cycle 2-like protein kinase 5) (Cell division protein kinase 13) (hCDK13) (Cholinesterase-related cell division controller) | Cyclin-dependent kinase which displays CTD kinase activity and is required for RNA splicing. Has CTD kinase activity by hyperphosphorylating the C-terminal heptapeptide repeat domain (CTD) of the largest RNA polymerase II subunit RPB1, thereby acting as a key regulator of transcription elongation. Required for RNA splicing, probably by phosphorylating SRSF1/SF2. Required during hematopoiesis. In case of infection by HIV-1 virus, interacts with HIV-1 Tat protein acetylated at 'Lys-50' and 'Lys-51', thereby increasing HIV-1 mRNA splicing and promoting the production of the doubly spliced HIV-1 protein Nef. {ECO:0000269|PubMed:16721827, ECO:0000269|PubMed:1731328, ECO:0000269|PubMed:18480452, ECO:0000269|PubMed:20952539}. |
Q14159 | SPIDR | S826 | ochoa | DNA repair-scaffolding protein (Scaffolding protein involved in DNA repair) | Plays a role in DNA double-strand break (DBS) repair via homologous recombination (HR). Serves as a scaffolding protein that helps to promote the recruitment of DNA-processing enzymes like the helicase BLM and recombinase RAD51 to site of DNA damage, and hence contributes to maintain genomic integrity. {ECO:0000269|PubMed:23509288, ECO:0000269|PubMed:23754376, ECO:0000269|PubMed:27967308, ECO:0000269|PubMed:34697795}. |
Q14493 | SLBP | S20 | ochoa|psp | Histone RNA hairpin-binding protein (Histone stem-loop-binding protein) | RNA-binding protein involved in the histone pre-mRNA processing (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Binds the stem-loop structure of replication-dependent histone pre-mRNAs and contributes to efficient 3'-end processing by stabilizing the complex between histone pre-mRNA and U7 small nuclear ribonucleoprotein (snRNP), via the histone downstream element (HDE) (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Plays an important role in targeting mature histone mRNA from the nucleus to the cytoplasm and to the translation machinery (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Stabilizes mature histone mRNA and could be involved in cell-cycle regulation of histone gene expression (PubMed:12588979, PubMed:19155325, PubMed:8957003, PubMed:9049306). Involved in the mechanism by which growing oocytes accumulate histone proteins that support early embryogenesis (By similarity). Binds to the 5' side of the stem-loop structure of histone pre-mRNAs (By similarity). {ECO:0000250|UniProtKB:P97440, ECO:0000269|PubMed:12588979, ECO:0000269|PubMed:19155325, ECO:0000269|PubMed:8957003, ECO:0000269|PubMed:9049306}. |
Q14966 | ZNF638 | S560 | ochoa | Zinc finger protein 638 (Cutaneous T-cell lymphoma-associated antigen se33-1) (CTCL-associated antigen se33-1) (Nuclear protein 220) (Zinc finger matrin-like protein) | Transcription factor that binds to cytidine clusters in double-stranded DNA (PubMed:30487602, PubMed:8647861). Plays a key role in the silencing of unintegrated retroviral DNA: some part of the retroviral DNA formed immediately after infection remains unintegrated in the host genome and is transcriptionally repressed (PubMed:30487602). Mediates transcriptional repression of unintegrated viral DNA by specifically binding to the cytidine clusters of retroviral DNA and mediating the recruitment of chromatin silencers, such as the HUSH complex, SETDB1 and the histone deacetylases HDAC1 and HDAC4 (PubMed:30487602). Acts as an early regulator of adipogenesis by acting as a transcription cofactor of CEBPs (CEBPA, CEBPD and/or CEBPG), controlling the expression of PPARG and probably of other proadipogenic genes, such as SREBF1 (By similarity). May also regulate alternative splicing of target genes during adipogenesis (By similarity). {ECO:0000250|UniProtKB:Q61464, ECO:0000269|PubMed:30487602, ECO:0000269|PubMed:8647861}. |
Q15678 | PTPN14 | S314 | ochoa | Tyrosine-protein phosphatase non-receptor type 14 (EC 3.1.3.48) (Protein-tyrosine phosphatase pez) | Protein tyrosine phosphatase which may play a role in the regulation of lymphangiogenesis, cell-cell adhesion, cell-matrix adhesion, cell migration, cell growth and also regulates TGF-beta gene expression, thereby modulating epithelial-mesenchymal transition. Mediates beta-catenin dephosphorylation at adhesion junctions. Acts as a negative regulator of the oncogenic property of YAP, a downstream target of the hippo pathway, in a cell density-dependent manner. May function as a tumor suppressor. {ECO:0000269|PubMed:10934049, ECO:0000269|PubMed:12808048, ECO:0000269|PubMed:17893246, ECO:0000269|PubMed:20826270, ECO:0000269|PubMed:22233626, ECO:0000269|PubMed:22525271, ECO:0000269|PubMed:22948661}. |
Q16584 | MAP3K11 | S507 | ochoa | Mitogen-activated protein kinase kinase kinase 11 (EC 2.7.11.25) (Mixed lineage kinase 3) (Src-homology 3 domain-containing proline-rich kinase) | Activates the JUN N-terminal pathway. Required for serum-stimulated cell proliferation and for mitogen and cytokine activation of MAPK14 (p38), MAPK3 (ERK) and MAPK8 (JNK1) through phosphorylation and activation of MAP2K4/MKK4 and MAP2K7/MKK7. Plays a role in mitogen-stimulated phosphorylation and activation of BRAF, but does not phosphorylate BRAF directly. Influences microtubule organization during the cell cycle. {ECO:0000269|PubMed:12529434, ECO:0000269|PubMed:15258589, ECO:0000269|PubMed:8195146, ECO:0000269|PubMed:9003778}. |
Q53GS9 | USP39 | S46 | ochoa | Ubiquitin carboxyl-terminal hydrolase 39 (EC 3.4.19.12) (SAD1 homolog) (U4/U6.U5 tri-snRNP-associated 65 kDa protein) | Deubiquitinating enzyme that plays a role in many cellular processes including cellular antiviral response, epithelial morphogenesis, DNA repair or B-cell development (PubMed:33127822, PubMed:34614178). Plays a role in pre-mRNA splicing as a component of the U4/U6-U5 tri-snRNP, one of the building blocks of the precatalytic spliceosome (PubMed:11350945, PubMed:26912367). Specifically regulates immunoglobulin gene rearrangement in a spliceosome-dependent manner, which involves modulating chromatin interactions at the Igh locus and therefore plays an essential role in B-cell development (By similarity). Regulates AURKB mRNA levels, and thereby plays a role in cytokinesis and in the spindle checkpoint (PubMed:18728397). Regulates apoptosis and G2/M cell cycle checkpoint in response to DNA damage by deubiquitinating and stabilizing CHK2 (PubMed:30771428). Also plays an important role in DNA repair by controlling the recruitment of XRCC4/LIG4 to DNA double-strand breaks for non-homologous end-joining repair (PubMed:34614178). Participates in antiviral activity by affecting the type I IFN signaling by stabilizing STAT1 and decreasing its 'Lys-6'-linked ubiquitination (PubMed:33127822). Contributes to non-canonical Wnt signaling during epidermal differentiation (By similarity). Acts as a negative regulator NF-kappa-B activation through deubiquitination of 'Lys-48'-linked ubiquitination of NFKBIA (PubMed:36651806). {ECO:0000250|UniProtKB:Q3TIX9, ECO:0000269|PubMed:11350945, ECO:0000269|PubMed:18728397, ECO:0000269|PubMed:26912367, ECO:0000269|PubMed:30771428, ECO:0000269|PubMed:33127822, ECO:0000269|PubMed:34614178, ECO:0000269|PubMed:36651806}. |
Q5VT97 | SYDE2 | S64 | ochoa | Rho GTPase-activating protein SYDE2 (Synapse defective protein 1 homolog 2) (Protein syd-1 homolog 2) | GTPase activator for the Rho-type GTPases by converting them to an inactive GDP-bound state. {ECO:0000250}. |
Q6PL18 | ATAD2 | S327 | ochoa | ATPase family AAA domain-containing protein 2 (EC 3.6.1.-) (AAA nuclear coregulator cancer-associated protein) (ANCCA) | May be a transcriptional coactivator of the nuclear receptor ESR1 required to induce the expression of a subset of estradiol target genes, such as CCND1, MYC and E2F1. May play a role in the recruitment or occupancy of CREBBP at some ESR1 target gene promoters. May be required for histone hyperacetylation. Involved in the estrogen-induced cell proliferation and cell cycle progression of breast cancer cells. {ECO:0000269|PubMed:17998543}. |
Q6UXT9 | ABHD15 | S434 | ochoa | Protein ABHD15 (Alpha/beta hydrolase domain-containing protein 15) (Abhydrolase domain-containing protein 15) | May regulate adipocyte lipolysis and liver lipid accumulation. {ECO:0000250|UniProtKB:Q5F2F2}. |
Q6Y7W6 | GIGYF2 | S236 | ochoa | GRB10-interacting GYF protein 2 (PERQ amino acid-rich with GYF domain-containing protein 2) (Trinucleotide repeat-containing gene 15 protein) | Key component of the 4EHP-GYF2 complex, a multiprotein complex that acts as a repressor of translation initiation (PubMed:22751931, PubMed:31439631, PubMed:35878012). In the 4EHP-GYF2 complex, acts as a factor that bridges EIF4E2 to ZFP36/TTP, linking translation repression with mRNA decay (PubMed:31439631). Also recruits and bridges the association of the 4EHP complex with the decapping effector protein DDX6, which is required for the ZFP36/TTP-mediated down-regulation of AU-rich mRNA (PubMed:31439631). May act cooperatively with GRB10 to regulate tyrosine kinase receptor signaling, including IGF1 and insulin receptors (PubMed:12771153). In association with EIF4E2, assists ribosome-associated quality control (RQC) by sequestering the mRNA cap, blocking ribosome initiation and decreasing the translational load on problematic messages. Part of a pathway that works in parallel to RQC-mediated degradation of the stalled nascent polypeptide (PubMed:32726578). GIGYF2 and EIF4E2 work downstream and independently of ZNF598, which seems to work as a scaffold that can recruit them to faulty mRNA even if alternative recruitment mechanisms may exist (PubMed:32726578). {ECO:0000269|PubMed:12771153, ECO:0000269|PubMed:22751931, ECO:0000269|PubMed:31439631, ECO:0000269|PubMed:32726578, ECO:0000269|PubMed:35878012}.; FUNCTION: (Microbial infection) Upon SARS coronavirus-2/SARS-CoV-2 infection, the interaction with non-structural protein 2 (nsp2) enhances GIGYF2 binding to EIF4E2 and increases repression of translation initiation of genes involved in antiviral innate immune response such as IFNB1. {ECO:0000269|PubMed:35878012}. |
Q7Z6J6 | FRMD5 | S354 | ochoa | FERM domain-containing protein 5 | May be involved in regulation of cell migration (PubMed:22846708, PubMed:25448675). May regulate cell-matrix interactions via its interaction with ITGB5 and modifying ITGB5 cytoplasmic tail interactions such as with FERMT2 and TLN1. May regulate ROCK1 kinase activity possibly involved in regulation of actin stress fiber formation (PubMed:25448675). |
Q86VQ6 | TXNRD3 | S32 | ochoa | Thioredoxin reductase 3 (EC 1.8.1.9) (Thioredoxin and glutathione reductase) (Thioredoxin reductase 3 intronic transcript 1) (Thioredoxin reductase 3 neighbor gene) (Thioredoxin reductase TR2) | Displays thioredoxin reductase, glutaredoxin and glutathione reductase activities. Catalyzes disulfide bond isomerization. Promotes disulfide bond formation between GPX4 and various sperm proteins and may play a role in sperm maturation by promoting formation of sperm structural components (By similarity). {ECO:0000250|UniProtKB:Q99MD6}. |
Q86X10 | RALGAPB | S1453 | ochoa | Ral GTPase-activating protein subunit beta (p170) | Non-catalytic subunit of the heterodimeric RalGAP1 and RalGAP2 complexes which act as GTPase activators for the Ras-like small GTPases RALA and RALB. {ECO:0000250}. |
Q8IUW3 | SPATA2L | S332 | ochoa | Spermatogenesis-associated protein 2-like protein (SPATA2-like protein) | None |
Q8IWQ3 | BRSK2 | S393 | ochoa | Serine/threonine-protein kinase BRSK2 (EC 2.7.11.1) (Brain-selective kinase 2) (EC 2.7.11.26) (Brain-specific serine/threonine-protein kinase 2) (BR serine/threonine-protein kinase 2) (Serine/threonine-protein kinase 29) (Serine/threonine-protein kinase SAD-A) | Serine/threonine-protein kinase that plays a key role in polarization of neurons and axonogenesis, cell cycle progress and insulin secretion. Phosphorylates CDK16, CDC25C, MAPT/TAU, PAK1 and WEE1. Following phosphorylation and activation by STK11/LKB1, acts as a key regulator of polarization of cortical neurons, probably by mediating phosphorylation of microtubule-associated proteins such as MAPT/TAU at 'Thr-529' and 'Ser-579'. Also regulates neuron polarization by mediating phosphorylation of WEE1 at 'Ser-642' in postmitotic neurons, leading to down-regulate WEE1 activity in polarized neurons. Plays a role in the regulation of the mitotic cell cycle progress and the onset of mitosis. Plays a role in the regulation of insulin secretion in response to elevated glucose levels, probably via phosphorylation of CDK16 and PAK1. While BRSK2 phosphorylated at Thr-174 can inhibit insulin secretion (PubMed:22798068), BRSK2 phosphorylated at Thr-260 can promote insulin secretion (PubMed:22669945). Regulates reorganization of the actin cytoskeleton. May play a role in the apoptotic response triggered by endoplasmic reticulum (ER) stress. {ECO:0000269|PubMed:14976552, ECO:0000269|PubMed:20026642, ECO:0000269|PubMed:21985311, ECO:0000269|PubMed:22669945, ECO:0000269|PubMed:22798068, ECO:0000269|PubMed:23029325}. |
Q8IXT5 | RBM12B | S874 | ochoa | RNA-binding protein 12B (RNA-binding motif protein 12B) | None |
Q8IY33 | MICALL2 | S649 | ochoa | MICAL-like protein 2 (Junctional Rab13-binding protein) (Molecule interacting with CasL-like 2) (MICAL-L2) | Effector of small Rab GTPases which is involved in junctional complexes assembly through the regulation of cell adhesion molecules transport to the plasma membrane and actin cytoskeleton reorganization. Regulates the endocytic recycling of occludins, claudins and E-cadherin to the plasma membrane and may thereby regulate the establishment of tight junctions and adherens junctions. In parallel, may regulate actin cytoskeleton reorganization directly through interaction with F-actin or indirectly through actinins and filamins. Most probably involved in the processes of epithelial cell differentiation, cell spreading and neurite outgrowth (By similarity). Undergoes liquid-liquid phase separation to form tubular recycling endosomes. Plays 2 sequential roles in the biogenesis of tubular recycling endosomes: first organizes phase separation and then the closed form formed by interaction with RAB8A promotes endosomal tubulation (By similarity). {ECO:0000250, ECO:0000250|UniProtKB:Q3TN34}. |
Q8IYB3 | SRRM1 | S551 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | S562 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IYB3 | SRRM1 | T572 | ochoa | Serine/arginine repetitive matrix protein 1 (SR-related nuclear matrix protein of 160 kDa) (SRm160) (Ser/Arg-related nuclear matrix protein) | Part of pre- and post-splicing multiprotein mRNP complexes. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Involved in numerous pre-mRNA processing events. Promotes constitutive and exonic splicing enhancer (ESE)-dependent splicing activation by bridging together sequence-specific (SR family proteins, SFRS4, SFRS5 and TRA2B/SFRS10) and basal snRNP (SNRP70 and SNRPA1) factors of the spliceosome. Stimulates mRNA 3'-end cleavage independently of the formation of an exon junction complex. Binds both pre-mRNA and spliced mRNA 20-25 nt upstream of exon-exon junctions. Binds RNA and DNA with low sequence specificity and has similar preference for either double- or single-stranded nucleic acid substrates. {ECO:0000269|PubMed:10339552, ECO:0000269|PubMed:10668804, ECO:0000269|PubMed:11739730, ECO:0000269|PubMed:12600940, ECO:0000269|PubMed:12944400, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q8IZC7 | ZNF101 | S152 | ochoa | Zinc finger protein 101 (Zinc finger protein HZF12) | May be involved in transcriptional regulation. |
Q8N3V7 | SYNPO | S501 | ochoa | Synaptopodin | Actin-associated protein that may play a role in modulating actin-based shape and motility of dendritic spines and renal podocyte foot processes. Seems to be essential for the formation of spine apparatuses in spines of telencephalic neurons, which is involved in synaptic plasticity (By similarity). {ECO:0000250}. |
Q8TF44 | C2CD4C | S273 | ochoa | C2 calcium-dependent domain-containing protein 4C (Nuclear-localized factor 3) (Protein FAM148C) | None |
Q96E09 | PABIR1 | S189 | ochoa | PPP2R1A-PPP2R2A-interacting phosphatase regulator 1 (PABIR family member 1) | Acts as an inhibitor of serine/threonine-protein phosphatase 2A (PP2A) activity (PubMed:27588481, PubMed:33108758, PubMed:38123684). Inhibits PP2A activity by blocking the substrate binding site on PPP2R2A and the active site of PPP2CA (PubMed:38123684). Potentiates ubiquitin-mediated proteasomal degradation of serine/threonine-protein phosphatase 2A catalytic subunit alpha (PPP2CA) (PubMed:27588481). Inhibits PP2A-mediated dephosphorylation of WEE1, promoting ubiquitin-mediated proteolysis of WEE1, thereby releasing G2/M checkpoint (PubMed:33108758). {ECO:0000269|PubMed:27588481, ECO:0000269|PubMed:33108758, ECO:0000269|PubMed:38123684}. |
Q96T37 | RBM15 | S656 | ochoa | RNA-binding protein 15 (One-twenty two protein 1) (RNA-binding motif protein 15) | RNA-binding protein that acts as a key regulator of N6-methyladenosine (m6A) methylation of RNAs, thereby regulating different processes, such as hematopoietic cell homeostasis, alternative splicing of mRNAs and X chromosome inactivation mediated by Xist RNA (PubMed:27602518). Associated component of the WMM complex, a complex that mediates N6-methyladenosine (m6A) methylation of RNAs, a modification that plays a role in the efficiency of mRNA splicing and RNA processing (By similarity). Plays a key role in m6A methylation, possibly by binding target RNAs and recruiting the WMM complex (PubMed:27602518). Involved in random X inactivation mediated by Xist RNA: acts by binding Xist RNA and recruiting the WMM complex, which mediates m6A methylation, leading to target YTHDC1 reader on Xist RNA and promoting transcription repression activity of Xist (PubMed:27602518). Required for the development of multiple tissues, such as the maintenance of the homeostasis of long-term hematopoietic stem cells and for megakaryocyte (MK) and B-cell differentiation (By similarity). Regulates megakaryocyte differentiation by regulating alternative splicing of genes important for megakaryocyte differentiation; probably regulates alternative splicing via m6A regulation (PubMed:26575292). Required for placental vascular branching morphogenesis and embryonic development of the heart and spleen (By similarity). Acts as a regulator of thrombopoietin response in hematopoietic stem cells by regulating alternative splicing of MPL (By similarity). May also function as an mRNA export factor, stimulating export and expression of RTE-containing mRNAs which are present in many retrotransposons that require to be exported prior to splicing (PubMed:17001072, PubMed:19786495). High affinity binding of pre-mRNA to RBM15 may allow targeting of the mRNP to the export helicase DBP5 in a manner that is independent of splicing-mediated NXF1 deposition, resulting in export prior to splicing (PubMed:17001072, PubMed:19786495). May be implicated in HOX gene regulation (PubMed:11344311). {ECO:0000250|UniProtKB:Q0VBL3, ECO:0000269|PubMed:17001072, ECO:0000269|PubMed:19786495, ECO:0000269|PubMed:26575292, ECO:0000269|PubMed:27602518, ECO:0000305|PubMed:11344311}. |
Q99612 | KLF6 | S192 | ochoa | Krueppel-like factor 6 (B-cell-derived protein 1) (Core promoter element-binding protein) (GC-rich sites-binding factor GBF) (Proto-oncogene BCD1) (Suppressor of tumorigenicity 12 protein) (Transcription factor Zf9) | Transcriptional activator (By similarity). Binds a GC box motif. Could play a role in B-cell growth and development. {ECO:0000250}. |
Q9BRD0 | BUD13 | S211 | ochoa | BUD13 homolog | Involved in pre-mRNA splicing as component of the activated spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000305|PubMed:33509932}. |
Q9BYW2 | SETD2 | S438 | ochoa | Histone-lysine N-methyltransferase SETD2 (EC 2.1.1.359) (HIF-1) (Huntingtin yeast partner B) (Huntingtin-interacting protein 1) (HIP-1) (Huntingtin-interacting protein B) (Lysine N-methyltransferase 3A) (Protein-lysine N-methyltransferase SETD2) (EC 2.1.1.-) (SET domain-containing protein 2) (hSET2) (p231HBP) | Histone methyltransferase that specifically trimethylates 'Lys-36' of histone H3 (H3K36me3) using dimethylated 'Lys-36' (H3K36me2) as substrate (PubMed:16118227, PubMed:19141475, PubMed:21526191, PubMed:21792193, PubMed:23043551, PubMed:27474439). It is capable of trimethylating unmethylated H3K36 (H3K36me0) in vitro (PubMed:19332550). Represents the main enzyme generating H3K36me3, a specific tag for epigenetic transcriptional activation (By similarity). Plays a role in chromatin structure modulation during elongation by coordinating recruitment of the FACT complex and by interacting with hyperphosphorylated POLR2A (PubMed:23325844). Acts as a key regulator of DNA mismatch repair in G1 and early S phase by generating H3K36me3, a mark required to recruit MSH6 subunit of the MutS alpha complex: early recruitment of the MutS alpha complex to chromatin to be replicated allows a quick identification of mismatch DNA to initiate the mismatch repair reaction (PubMed:23622243). Required for DNA double-strand break repair in response to DNA damage: acts by mediating formation of H3K36me3, promoting recruitment of RAD51 and DNA repair via homologous recombination (HR) (PubMed:24843002). Acts as a tumor suppressor (PubMed:24509477). H3K36me3 also plays an essential role in the maintenance of a heterochromatic state, by recruiting DNA methyltransferase DNMT3A (PubMed:27317772). H3K36me3 is also enhanced in intron-containing genes, suggesting that SETD2 recruitment is enhanced by splicing and that splicing is coupled to recruitment of elongating RNA polymerase (PubMed:21792193). Required during angiogenesis (By similarity). Required for endoderm development by promoting embryonic stem cell differentiation toward endoderm: acts by mediating formation of H3K36me3 in distal promoter regions of FGFR3, leading to regulate transcription initiation of FGFR3 (By similarity). In addition to histones, also mediates methylation of other proteins, such as tubulins and STAT1 (PubMed:27518565, PubMed:28753426). Trimethylates 'Lys-40' of alpha-tubulins such as TUBA1B (alpha-TubK40me3); alpha-TubK40me3 is required for normal mitosis and cytokinesis and may be a specific tag in cytoskeletal remodeling (PubMed:27518565). Involved in interferon-alpha-induced antiviral defense by mediating both monomethylation of STAT1 at 'Lys-525' and catalyzing H3K36me3 on promoters of some interferon-stimulated genes (ISGs) to activate gene transcription (PubMed:28753426). {ECO:0000250|UniProtKB:E9Q5F9, ECO:0000269|PubMed:16118227, ECO:0000269|PubMed:19141475, ECO:0000269|PubMed:21526191, ECO:0000269|PubMed:21792193, ECO:0000269|PubMed:23043551, ECO:0000269|PubMed:23325844, ECO:0000269|PubMed:23622243, ECO:0000269|PubMed:24509477, ECO:0000269|PubMed:24843002, ECO:0000269|PubMed:27317772, ECO:0000269|PubMed:27474439, ECO:0000269|PubMed:27518565, ECO:0000269|PubMed:28753426}.; FUNCTION: (Microbial infection) Recruited to the promoters of adenovirus 12 E1A gene in case of infection, possibly leading to regulate its expression. {ECO:0000269|PubMed:11461154}. |
Q9H706 | GAREM1 | S546 | ochoa | GRB2-associated and regulator of MAPK protein 1 (GRB2-associated and regulator of MAPK1) | [Isoform 1]: Acts as an adapter protein that plays a role in intracellular signaling cascades triggered either by the cell surface activated epidermal growth factor receptor and/or cytoplasmic protein tyrosine kinases. Promotes activation of the MAPK/ERK signaling pathway. Plays a role in the regulation of cell proliferation. {ECO:0000269|PubMed:19509291}. |
Q9HCG8 | CWC22 | S91 | ochoa | Pre-mRNA-splicing factor CWC22 homolog (Nucampholin homolog) (fSAPb) | Required for pre-mRNA splicing as component of the spliceosome (PubMed:11991638, PubMed:12226669, PubMed:22961380, PubMed:28076346, PubMed:28502770, PubMed:29301961, PubMed:29360106). As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). Promotes exon-junction complex (EJC) assembly (PubMed:22959432, PubMed:22961380). Hinders EIF4A3 from non-specifically binding RNA and escorts it to the splicing machinery to promote EJC assembly on mature mRNAs. Through its role in EJC assembly, required for nonsense-mediated mRNA decay. {ECO:0000269|PubMed:11991638, ECO:0000269|PubMed:12226669, ECO:0000269|PubMed:22959432, ECO:0000269|PubMed:22961380, ECO:0000269|PubMed:23236153, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000305|PubMed:33509932}. |
Q9NRL2 | BAZ1A | S270 | ochoa | Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1) | Regulatory subunit of the ATP-dependent ACF-1 and ACF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and slide edge- and center-positioned histone octamers away from their original location on the DNA template to facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:17099699, PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template in an ATP-dependent manner (PubMed:14759371, PubMed:17099699, PubMed:28801535). The ACF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the ACF-5 ISWI chromatin remodeling complex (PubMed:28801535). Has a role in sensing the length of DNA which flank nucleosomes, which modulates the nucleosome spacing activity of the ACF-5 ISWI chromatin remodeling complex (PubMed:17099699). Involved in DNA replication and together with SMARCA5/SNF2H is required for replication of pericentric heterochromatin in S-phase (PubMed:12434153). May have a role in nuclear receptor-mediated transcription repression (PubMed:17519354). {ECO:0000269|PubMed:12434153, ECO:0000269|PubMed:14759371, ECO:0000269|PubMed:17099699, ECO:0000269|PubMed:17519354, ECO:0000269|PubMed:28801535}. |
Q9NRL2 | BAZ1A | S1353 | ochoa | Bromodomain adjacent to zinc finger domain protein 1A (ATP-dependent chromatin-remodeling protein) (ATP-utilizing chromatin assembly and remodeling factor 1) (hACF1) (CHRAC subunit ACF1) (Williams syndrome transcription factor-related chromatin-remodeling factor 180) (WCRF180) (hWALp1) | Regulatory subunit of the ATP-dependent ACF-1 and ACF-5 ISWI chromatin remodeling complexes, which form ordered nucleosome arrays on chromatin and slide edge- and center-positioned histone octamers away from their original location on the DNA template to facilitate access to DNA during DNA-templated processes such as DNA replication, transcription, and repair (PubMed:17099699, PubMed:28801535). Both complexes regulate the spacing of nucleosomes along the chromatin and have the ability to slide mononucleosomes to the center of a DNA template in an ATP-dependent manner (PubMed:14759371, PubMed:17099699, PubMed:28801535). The ACF-1 ISWI chromatin remodeling complex has a lower ATP hydrolysis rate than the ACF-5 ISWI chromatin remodeling complex (PubMed:28801535). Has a role in sensing the length of DNA which flank nucleosomes, which modulates the nucleosome spacing activity of the ACF-5 ISWI chromatin remodeling complex (PubMed:17099699). Involved in DNA replication and together with SMARCA5/SNF2H is required for replication of pericentric heterochromatin in S-phase (PubMed:12434153). May have a role in nuclear receptor-mediated transcription repression (PubMed:17519354). {ECO:0000269|PubMed:12434153, ECO:0000269|PubMed:14759371, ECO:0000269|PubMed:17099699, ECO:0000269|PubMed:17519354, ECO:0000269|PubMed:28801535}. |
Q9NYF8 | BCLAF1 | S648 | ochoa | Bcl-2-associated transcription factor 1 (Btf) (BCLAF1 and THRAP3 family member 1) | Death-promoting transcriptional repressor. May be involved in cyclin-D1/CCND1 mRNA stability through the SNARP complex which associates with both the 3'end of the CCND1 gene and its mRNA. {ECO:0000269|PubMed:18794151}. |
Q9UQ35 | SRRM2 | S2398 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Q9UQ35 | SRRM2 | Y2693 | ochoa | Serine/arginine repetitive matrix protein 2 (300 kDa nuclear matrix antigen) (Serine/arginine-rich splicing factor-related nuclear matrix protein of 300 kDa) (SR-related nuclear matrix protein of 300 kDa) (Ser/Arg-related nuclear matrix protein of 300 kDa) (Splicing coactivator subunit SRm300) (Tax-responsive enhancer element-binding protein 803) (TaxREB803) | Required for pre-mRNA splicing as component of the spliceosome. As a component of the minor spliceosome, involved in the splicing of U12-type introns in pre-mRNAs (Probable). {ECO:0000269|PubMed:19854871, ECO:0000269|PubMed:28076346, ECO:0000269|PubMed:28502770, ECO:0000269|PubMed:29301961, ECO:0000269|PubMed:29360106, ECO:0000269|PubMed:29361316, ECO:0000269|PubMed:30705154, ECO:0000269|PubMed:9531537, ECO:0000305|PubMed:33509932}. |
Download
reactome_id | name | p | -log10_p |
---|---|---|---|
R-HSA-72203 | Processing of Capped Intron-Containing Pre-mRNA | 0.000005 | 5.265 |
R-HSA-72202 | Transport of Mature Transcript to Cytoplasm | 0.000092 | 4.035 |
R-HSA-72172 | mRNA Splicing | 0.000084 | 4.076 |
R-HSA-72163 | mRNA Splicing - Major Pathway | 0.000057 | 4.241 |
R-HSA-176974 | Unwinding of DNA | 0.000132 | 3.880 |
R-HSA-159236 | Transport of Mature mRNA derived from an Intron-Containing Transcript | 0.000510 | 3.292 |
R-HSA-68962 | Activation of the pre-replicative complex | 0.003097 | 2.509 |
R-HSA-73856 | RNA Polymerase II Transcription Termination | 0.002358 | 2.627 |
R-HSA-8935964 | RUNX1 regulates expression of components of tight junctions | 0.001924 | 2.716 |
R-HSA-8953854 | Metabolism of RNA | 0.003411 | 2.467 |
R-HSA-9825895 | Regulation of MITF-M-dependent genes involved in DNA replication, damage repair ... | 0.003582 | 2.446 |
R-HSA-69190 | DNA strand elongation | 0.003601 | 2.444 |
R-HSA-9931510 | Phosphorylated BMAL1:CLOCK (ARNTL:CLOCK) activates expression of core clock gene... | 0.002226 | 2.653 |
R-HSA-176187 | Activation of ATR in response to replication stress | 0.003870 | 2.412 |
R-HSA-159230 | Transport of the SLBP Dependant Mature mRNA | 0.004152 | 2.382 |
R-HSA-159234 | Transport of Mature mRNAs Derived from Intronless Transcripts | 0.006471 | 2.189 |
R-HSA-72187 | mRNA 3'-end processing | 0.012498 | 1.903 |
R-HSA-9931521 | The CRY:PER:kinase complex represses transactivation by the BMAL:CLOCK (ARNTL:CL... | 0.012398 | 1.907 |
R-HSA-68949 | Orc1 removal from chromatin | 0.012498 | 1.903 |
R-HSA-2980766 | Nuclear Envelope Breakdown | 0.015445 | 1.811 |
R-HSA-9834899 | Specification of the neural plate border | 0.015945 | 1.797 |
R-HSA-9944997 | Loss of Function of KMT2D in MLL4 Complex Formation in Kabuki Syndrome | 0.038971 | 1.409 |
R-HSA-4717374 | Defective DPM1 causes DPM1-CDG | 0.038971 | 1.409 |
R-HSA-9944971 | Loss of Function of KMT2D in Kabuki Syndrome | 0.038971 | 1.409 |
R-HSA-4719360 | Defective DPM3 causes DPM3-CDG | 0.038971 | 1.409 |
R-HSA-4719377 | Defective DPM2 causes DPM2-CDG | 0.038971 | 1.409 |
R-HSA-5619107 | Defective TPR may confer susceptibility towards thyroid papillary carcinoma (TPC... | 0.033738 | 1.472 |
R-HSA-1855196 | IP3 and IP4 transport between cytosol and nucleus | 0.035457 | 1.450 |
R-HSA-1855229 | IP6 and IP7 transport between cytosol and nucleus | 0.035457 | 1.450 |
R-HSA-1855170 | IPs transport between nucleus and cytosol | 0.038995 | 1.409 |
R-HSA-159227 | Transport of the SLBP independent Mature mRNA | 0.038995 | 1.409 |
R-HSA-3301854 | Nuclear Pore Complex (NPC) Disassembly | 0.044540 | 1.351 |
R-HSA-191650 | Regulation of gap junction activity | 0.046582 | 1.332 |
R-HSA-9705677 | SARS-CoV-2 targets PDZ proteins in cell-cell junction | 0.046582 | 1.332 |
R-HSA-180910 | Vpr-mediated nuclear import of PICs | 0.048389 | 1.315 |
R-HSA-170822 | Regulation of Glucokinase by Glucokinase Regulatory Protein | 0.040812 | 1.389 |
R-HSA-68867 | Assembly of the pre-replicative complex | 0.049592 | 1.305 |
R-HSA-180746 | Nuclear import of Rev protein | 0.042661 | 1.370 |
R-HSA-69481 | G2/M Checkpoints | 0.027275 | 1.564 |
R-HSA-165054 | Rev-mediated nuclear export of HIV RNA | 0.050358 | 1.298 |
R-HSA-69052 | Switching of origins to a post-replicative state | 0.027297 | 1.564 |
R-HSA-69620 | Cell Cycle Checkpoints | 0.024215 | 1.616 |
R-HSA-69278 | Cell Cycle, Mitotic | 0.045229 | 1.345 |
R-HSA-9008059 | Interleukin-37 signaling | 0.033738 | 1.472 |
R-HSA-9833576 | CDH11 homotypic and heterotypic interactions | 0.061626 | 1.210 |
R-HSA-159231 | Transport of Mature mRNA Derived from an Intronless Transcript | 0.052355 | 1.281 |
R-HSA-162699 | Synthesis of dolichyl-phosphate mannose | 0.061626 | 1.210 |
R-HSA-177243 | Interactions of Rev with host cellular proteins | 0.054380 | 1.265 |
R-HSA-176033 | Interactions of Vpr with host cellular proteins | 0.054380 | 1.265 |
R-HSA-168271 | Transport of Ribonucleoproteins into the Host Nucleus | 0.056432 | 1.248 |
R-HSA-9764302 | Regulation of CDH19 Expression and Function | 0.061626 | 1.210 |
R-HSA-3214841 | PKMTs methylate histone lysines | 0.056432 | 1.248 |
R-HSA-168276 | NS1 Mediated Effects on Host Pathways | 0.052355 | 1.281 |
R-HSA-77588 | SLBP Dependent Processing of Replication-Dependent Histone Pre-mRNAs | 0.083751 | 1.077 |
R-HSA-168333 | NEP/NS2 Interacts with the Cellular Export Machinery | 0.067085 | 1.173 |
R-HSA-69002 | DNA Replication Pre-Initiation | 0.072718 | 1.138 |
R-HSA-168274 | Export of Viral Ribonucleoproteins from Nucleus | 0.069290 | 1.159 |
R-HSA-1483249 | Inositol phosphate metabolism | 0.076969 | 1.114 |
R-HSA-69239 | Synthesis of DNA | 0.069945 | 1.155 |
R-HSA-351906 | Apoptotic cleavage of cell adhesion proteins | 0.083751 | 1.077 |
R-HSA-9931512 | Phosphorylation of CLOCK, acetylation of BMAL1 (ARNTL) at target gene promoters | 0.112448 | 0.949 |
R-HSA-9820865 | Z-decay: degradation of maternal mRNAs by zygotically expressed factors | 0.119482 | 0.923 |
R-HSA-9762292 | Regulation of CDH11 function | 0.098213 | 1.008 |
R-HSA-8876493 | InlA-mediated entry of Listeria monocytogenes into host cells | 0.105358 | 0.977 |
R-HSA-9931530 | Phosphorylation and nuclear translocation of the CRY:PER:kinase complex | 0.119482 | 0.923 |
R-HSA-2025928 | Calcineurin activates NFAT | 0.091010 | 1.041 |
R-HSA-429914 | Deadenylation-dependent mRNA decay | 0.099932 | 1.000 |
R-HSA-1236973 | Cross-presentation of particulate exogenous antigens (phagosomes) | 0.098213 | 1.008 |
R-HSA-191859 | snRNP Assembly | 0.099932 | 1.000 |
R-HSA-194441 | Metabolism of non-coding RNA | 0.099932 | 1.000 |
R-HSA-168325 | Viral Messenger RNA Synthesis | 0.104934 | 0.979 |
R-HSA-68882 | Mitotic Anaphase | 0.119804 | 0.922 |
R-HSA-2555396 | Mitotic Metaphase and Anaphase | 0.121144 | 0.917 |
R-HSA-9909396 | Circadian clock | 0.114626 | 0.941 |
R-HSA-6784531 | tRNA processing in the nucleus | 0.107460 | 0.969 |
R-HSA-69206 | G1/S Transition | 0.101391 | 0.994 |
R-HSA-68875 | Mitotic Prophase | 0.091899 | 1.037 |
R-HSA-429947 | Deadenylation of mRNA | 0.212339 | 0.673 |
R-HSA-141424 | Amplification of signal from the kinetochores | 0.172100 | 0.764 |
R-HSA-141444 | Amplification of signal from unattached kinetochores via a MAD2 inhibitory si... | 0.172100 | 0.764 |
R-HSA-72165 | mRNA Splicing - Minor Pathway | 0.349464 | 0.457 |
R-HSA-774815 | Nucleosome assembly | 0.344255 | 0.463 |
R-HSA-606279 | Deposition of new CENPA-containing nucleosomes at the centromere | 0.344255 | 0.463 |
R-HSA-69618 | Mitotic Spindle Checkpoint | 0.220905 | 0.656 |
R-HSA-181429 | Serotonin Neurotransmitter Release Cycle | 0.167193 | 0.777 |
R-HSA-933542 | TRAF6 mediated NF-kB activation | 0.212339 | 0.673 |
R-HSA-212676 | Dopamine Neurotransmitter Release Cycle | 0.199694 | 0.700 |
R-HSA-5607763 | CLEC7A (Dectin-1) induces NFAT activation | 0.133384 | 0.875 |
R-HSA-430039 | mRNA decay by 5' to 3' exoribonuclease | 0.153829 | 0.813 |
R-HSA-264642 | Acetylcholine Neurotransmitter Release Cycle | 0.186847 | 0.729 |
R-HSA-181430 | Norepinephrine Neurotransmitter Release Cycle | 0.212339 | 0.673 |
R-HSA-9646399 | Aggrephagy | 0.312120 | 0.506 |
R-HSA-9932298 | Degradation of CRY and PER proteins | 0.323002 | 0.491 |
R-HSA-8876384 | Listeria monocytogenes entry into host cells | 0.193296 | 0.714 |
R-HSA-2500257 | Resolution of Sister Chromatid Cohesion | 0.291218 | 0.536 |
R-HSA-75067 | Processing of Capped Intronless Pre-mRNA | 0.212339 | 0.673 |
R-HSA-9615933 | Postmitotic nuclear pore complex (NPC) reformation | 0.224786 | 0.648 |
R-HSA-6796648 | TP53 Regulates Transcription of DNA Repair Genes | 0.149831 | 0.824 |
R-HSA-9759475 | Regulation of CDH11 Expression and Function | 0.243091 | 0.614 |
R-HSA-9820841 | M-decay: degradation of maternal mRNAs by maternally stored factors | 0.317582 | 0.498 |
R-HSA-9764260 | Regulation of Expression and Function of Type II Classical Cadherins | 0.266832 | 0.574 |
R-HSA-69306 | DNA Replication | 0.155926 | 0.807 |
R-HSA-210500 | Glutamate Neurotransmitter Release Cycle | 0.224786 | 0.648 |
R-HSA-5693568 | Resolution of D-loop Structures through Holliday Junction Intermediates | 0.266832 | 0.574 |
R-HSA-9609690 | HCMV Early Events | 0.244631 | 0.611 |
R-HSA-5693537 | Resolution of D-Loop Structures | 0.272651 | 0.564 |
R-HSA-5357956 | TNFR1-induced NF-kappa-B signaling pathway | 0.230936 | 0.637 |
R-HSA-9930044 | Nuclear RNA decay | 0.266832 | 0.574 |
R-HSA-5578749 | Transcriptional regulation by small RNAs | 0.133554 | 0.874 |
R-HSA-9766229 | Degradation of CDH1 | 0.364846 | 0.438 |
R-HSA-9648025 | EML4 and NUDC in mitotic spindle formation | 0.250140 | 0.602 |
R-HSA-5609975 | Diseases associated with glycosylation precursor biosynthesis | 0.266832 | 0.574 |
R-HSA-68886 | M Phase | 0.218168 | 0.661 |
R-HSA-388844 | Receptor-type tyrosine-protein phosphatases | 0.147068 | 0.832 |
R-HSA-9675151 | Disorders of Developmental Biology | 0.153829 | 0.813 |
R-HSA-4419969 | Depolymerization of the Nuclear Lamina | 0.167193 | 0.777 |
R-HSA-2995410 | Nuclear Envelope (NE) Reassembly | 0.155342 | 0.809 |
R-HSA-9609646 | HCMV Infection | 0.363152 | 0.440 |
R-HSA-1266695 | Interleukin-7 signaling | 0.218587 | 0.660 |
R-HSA-2995383 | Initiation of Nuclear Envelope (NE) Reformation | 0.193296 | 0.714 |
R-HSA-9649948 | Signaling downstream of RAS mutants | 0.349464 | 0.457 |
R-HSA-6802946 | Signaling by moderate kinase activity BRAF mutants | 0.349464 | 0.457 |
R-HSA-6802955 | Paradoxical activation of RAF signaling by kinase inactive BRAF | 0.349464 | 0.457 |
R-HSA-1640170 | Cell Cycle | 0.127363 | 0.895 |
R-HSA-166208 | mTORC1-mediated signalling | 0.199694 | 0.700 |
R-HSA-157858 | Gap junction trafficking and regulation | 0.364846 | 0.438 |
R-HSA-6802949 | Signaling by RAS mutants | 0.349464 | 0.457 |
R-HSA-8878171 | Transcriptional regulation by RUNX1 | 0.311158 | 0.507 |
R-HSA-162909 | Host Interactions of HIV factors | 0.300001 | 0.523 |
R-HSA-70171 | Glycolysis | 0.220905 | 0.656 |
R-HSA-1855204 | Synthesis of IP3 and IP4 in the cytosol | 0.266832 | 0.574 |
R-HSA-5673000 | RAF activation | 0.278424 | 0.555 |
R-HSA-453279 | Mitotic G1 phase and G1/S transition | 0.142892 | 0.845 |
R-HSA-5357905 | Regulation of TNFR1 signaling | 0.349464 | 0.457 |
R-HSA-69242 | S Phase | 0.146578 | 0.834 |
R-HSA-1855183 | Synthesis of IP2, IP, and Ins in the cytosol | 0.224786 | 0.648 |
R-HSA-3769402 | Deactivation of the beta-catenin transactivating complex | 0.295472 | 0.529 |
R-HSA-437239 | Recycling pathway of L1 | 0.354632 | 0.450 |
R-HSA-3371453 | Regulation of HSF1-mediated heat shock response | 0.226733 | 0.644 |
R-HSA-3247509 | Chromatin modifying enzymes | 0.328502 | 0.483 |
R-HSA-9772755 | Formation of WDR5-containing histone-modifying complexes | 0.284152 | 0.546 |
R-HSA-5218920 | VEGFR2 mediated vascular permeability | 0.317582 | 0.498 |
R-HSA-1169408 | ISG15 antiviral mechanism | 0.141641 | 0.849 |
R-HSA-9705683 | SARS-CoV-2-host interactions | 0.315493 | 0.501 |
R-HSA-202433 | Generation of second messenger molecules | 0.312120 | 0.506 |
R-HSA-4839726 | Chromatin organization | 0.360991 | 0.443 |
R-HSA-8866910 | TFAP2 (AP-2) family regulates transcription of growth factors and their receptor... | 0.153829 | 0.813 |
R-HSA-70326 | Glucose metabolism | 0.279489 | 0.554 |
R-HSA-9705671 | SARS-CoV-2 activates/modulates innate and adaptive immune responses | 0.363641 | 0.439 |
R-HSA-4420097 | VEGFA-VEGFR2 Pathway | 0.273620 | 0.563 |
R-HSA-194138 | Signaling by VEGF | 0.305846 | 0.514 |
R-HSA-165159 | MTOR signalling | 0.328378 | 0.484 |
R-HSA-3371556 | Cellular response to heat stress | 0.291218 | 0.536 |
R-HSA-2028269 | Signaling by Hippo | 0.160538 | 0.794 |
R-HSA-111465 | Apoptotic cleavage of cellular proteins | 0.260967 | 0.583 |
R-HSA-162599 | Late Phase of HIV Life Cycle | 0.363641 | 0.439 |
R-HSA-211000 | Gene Silencing by RNA | 0.244277 | 0.612 |
R-HSA-8864260 | Transcriptional regulation by the AP-2 (TFAP2) family of transcription factors | 0.339004 | 0.470 |
R-HSA-75153 | Apoptotic execution phase | 0.349464 | 0.457 |
R-HSA-9692916 | SARS-CoV-1 activates/modulates innate immune responses | 0.379866 | 0.420 |
R-HSA-9758941 | Gastrulation | 0.383472 | 0.416 |
R-HSA-9856651 | MITF-M-dependent gene expression | 0.386284 | 0.413 |
R-HSA-72649 | Translation initiation complex formation | 0.389684 | 0.409 |
R-HSA-446652 | Interleukin-1 family signaling | 0.391892 | 0.407 |
R-HSA-6811436 | COPI-independent Golgi-to-ER retrograde traffic | 0.394535 | 0.404 |
R-HSA-1169410 | Antiviral mechanism by IFN-stimulated genes | 0.397477 | 0.401 |
R-HSA-72702 | Ribosomal scanning and start codon recognition | 0.399347 | 0.399 |
R-HSA-75893 | TNF signaling | 0.399347 | 0.399 |
R-HSA-3299685 | Detoxification of Reactive Oxygen Species | 0.399347 | 0.399 |
R-HSA-168273 | Influenza Viral RNA Transcription and Replication | 0.400261 | 0.398 |
R-HSA-913531 | Interferon Signaling | 0.400591 | 0.397 |
R-HSA-9764561 | Regulation of CDH1 Function | 0.404122 | 0.393 |
R-HSA-9610379 | HCMV Late Events | 0.405810 | 0.392 |
R-HSA-162587 | HIV Life Cycle | 0.405810 | 0.392 |
R-HSA-72662 | Activation of the mRNA upon binding of the cap-binding complex and eIFs, and sub... | 0.408859 | 0.388 |
R-HSA-201722 | Formation of the beta-catenin:TCF transactivating complex | 0.408859 | 0.388 |
R-HSA-877300 | Interferon gamma signaling | 0.411336 | 0.386 |
R-HSA-8943724 | Regulation of PTEN gene transcription | 0.418221 | 0.379 |
R-HSA-2428928 | IRS-related events triggered by IGF1R | 0.422847 | 0.374 |
R-HSA-2467813 | Separation of Sister Chromatids | 0.425039 | 0.372 |
R-HSA-8852276 | The role of GTSE1 in G2/M progression after G2 checkpoint | 0.427436 | 0.369 |
R-HSA-1660499 | Synthesis of PIPs at the plasma membrane | 0.427436 | 0.369 |
R-HSA-380284 | Loss of proteins required for interphase microtubule organization from the centr... | 0.431989 | 0.365 |
R-HSA-380259 | Loss of Nlp from mitotic centrosomes | 0.431989 | 0.365 |
R-HSA-5619102 | SLC transporter disorders | 0.433182 | 0.363 |
R-HSA-2428924 | IGF1R signaling cascade | 0.436506 | 0.360 |
R-HSA-2404192 | Signaling by Type 1 Insulin-like Growth Factor 1 Receptor (IGF1R) | 0.440988 | 0.356 |
R-HSA-72306 | tRNA processing | 0.443945 | 0.353 |
R-HSA-8854518 | AURKA Activation by TPX2 | 0.445434 | 0.351 |
R-HSA-5685942 | HDR through Homologous Recombination (HRR) | 0.449845 | 0.347 |
R-HSA-8936459 | RUNX1 regulates genes involved in megakaryocyte differentiation and platelet fun... | 0.454221 | 0.343 |
R-HSA-3371497 | HSP90 chaperone cycle for steroid hormone receptors (SHR) in the presence of lig... | 0.454221 | 0.343 |
R-HSA-1168372 | Downstream signaling events of B Cell Receptor (BCR) | 0.462870 | 0.335 |
R-HSA-427413 | NoRC negatively regulates rRNA expression | 0.467143 | 0.331 |
R-HSA-5620920 | Cargo trafficking to the periciliary membrane | 0.467143 | 0.331 |
R-HSA-168255 | Influenza Infection | 0.467744 | 0.330 |
R-HSA-380270 | Recruitment of mitotic centrosome proteins and complexes | 0.475589 | 0.323 |
R-HSA-1445148 | Translocation of SLC2A4 (GLUT4) to the plasma membrane | 0.475589 | 0.323 |
R-HSA-1222556 | ROS and RNS production in phagocytes | 0.479762 | 0.319 |
R-HSA-380287 | Centrosome maturation | 0.483902 | 0.315 |
R-HSA-69275 | G2/M Transition | 0.485837 | 0.314 |
R-HSA-453274 | Mitotic G2-G2/M phases | 0.490937 | 0.309 |
R-HSA-5617833 | Cilium Assembly | 0.496005 | 0.305 |
R-HSA-68877 | Mitotic Prometaphase | 0.503548 | 0.298 |
R-HSA-5250941 | Negative epigenetic regulation of rRNA expression | 0.504117 | 0.297 |
R-HSA-2565942 | Regulation of PLK1 Activity at G2/M Transition | 0.519722 | 0.284 |
R-HSA-6802957 | Oncogenic MAPK signaling | 0.523546 | 0.281 |
R-HSA-6794362 | Protein-protein interactions at synapses | 0.523546 | 0.281 |
R-HSA-2454202 | Fc epsilon receptor (FCERI) signaling | 0.528164 | 0.277 |
R-HSA-376176 | Signaling by ROBO receptors | 0.528164 | 0.277 |
R-HSA-380320 | Recruitment of NuMA to mitotic centrosomes | 0.538544 | 0.269 |
R-HSA-9663891 | Selective autophagy | 0.538544 | 0.269 |
R-HSA-5620912 | Anchoring of the basal body to the plasma membrane | 0.545866 | 0.263 |
R-HSA-112310 | Neurotransmitter release cycle | 0.545866 | 0.263 |
R-HSA-9730414 | MITF-M-regulated melanocyte development | 0.554283 | 0.256 |
R-HSA-9694516 | SARS-CoV-2 Infection | 0.564138 | 0.249 |
R-HSA-168928 | DDX58/IFIH1-mediated induction of interferon-alpha/beta | 0.567148 | 0.246 |
R-HSA-6807878 | COPI-mediated anterograde transport | 0.574020 | 0.241 |
R-HSA-381340 | Transcriptional regulation of white adipocyte differentiation | 0.574020 | 0.241 |
R-HSA-5607764 | CLEC7A (Dectin-1) signaling | 0.574020 | 0.241 |
R-HSA-975871 | MyD88 cascade initiated on plasma membrane | 0.580784 | 0.236 |
R-HSA-168176 | Toll Like Receptor 5 (TLR5) Cascade | 0.580784 | 0.236 |
R-HSA-168142 | Toll Like Receptor 10 (TLR10) Cascade | 0.580784 | 0.236 |
R-HSA-162906 | HIV Infection | 0.586039 | 0.232 |
R-HSA-1483255 | PI Metabolism | 0.593993 | 0.226 |
R-HSA-5619507 | Activation of HOX genes during differentiation | 0.603628 | 0.219 |
R-HSA-5617472 | Activation of anterior HOX genes in hindbrain development during early embryogen... | 0.603628 | 0.219 |
R-HSA-163125 | Post-translational modification: synthesis of GPI-anchored proteins | 0.603628 | 0.219 |
R-HSA-9692914 | SARS-CoV-1-host interactions | 0.609925 | 0.215 |
R-HSA-72706 | GTP hydrolysis and joining of the 60S ribosomal subunit | 0.616122 | 0.210 |
R-HSA-156827 | L13a-mediated translational silencing of Ceruloplasmin expression | 0.616122 | 0.210 |
R-HSA-1236975 | Antigen processing-Cross presentation | 0.616122 | 0.210 |
R-HSA-975138 | TRAF6 mediated induction of NFkB and MAP kinases upon TLR7/8 or 9 activation | 0.616122 | 0.210 |
R-HSA-975155 | MyD88 dependent cascade initiated on endosome | 0.619184 | 0.208 |
R-HSA-202403 | TCR signaling | 0.622222 | 0.206 |
R-HSA-975957 | Nonsense Mediated Decay (NMD) enhanced by the Exon Junction Complex (EJC) | 0.628226 | 0.202 |
R-HSA-927802 | Nonsense-Mediated Decay (NMD) | 0.628226 | 0.202 |
R-HSA-2871796 | FCERI mediated MAPK activation | 0.628226 | 0.202 |
R-HSA-5619115 | Disorders of transmembrane transporters | 0.628480 | 0.202 |
R-HSA-168181 | Toll Like Receptor 7/8 (TLR7/8) Cascade | 0.631192 | 0.200 |
R-HSA-5693567 | HDR through Homologous Recombination (HRR) or Single Strand Annealing (SSA) | 0.634135 | 0.198 |
R-HSA-168138 | Toll Like Receptor 9 (TLR9) Cascade | 0.639951 | 0.194 |
R-HSA-2871809 | FCERI mediated Ca+2 mobilization | 0.642825 | 0.192 |
R-HSA-72613 | Eukaryotic Translation Initiation | 0.645675 | 0.190 |
R-HSA-72737 | Cap-dependent Translation Initiation | 0.645675 | 0.190 |
R-HSA-373760 | L1CAM interactions | 0.645675 | 0.190 |
R-HSA-5693538 | Homology Directed Repair | 0.651309 | 0.186 |
R-HSA-166058 | MyD88:MAL(TIRAP) cascade initiated on plasma membrane | 0.654093 | 0.184 |
R-HSA-168188 | Toll Like Receptor TLR6:TLR2 Cascade | 0.654093 | 0.184 |
R-HSA-73886 | Chromosome Maintenance | 0.659594 | 0.181 |
R-HSA-168179 | Toll Like Receptor TLR1:TLR2 Cascade | 0.662312 | 0.179 |
R-HSA-181438 | Toll Like Receptor 2 (TLR2) Cascade | 0.662312 | 0.179 |
R-HSA-9816359 | Maternal to zygotic transition (MZT) | 0.665008 | 0.177 |
R-HSA-2132295 | MHC class II antigen presentation | 0.665008 | 0.177 |
R-HSA-9841922 | MLL4 and MLL3 complexes regulate expression of PPARG target genes in adipogenesi... | 0.672970 | 0.172 |
R-HSA-9851695 | Epigenetic regulation of adipogenesis genes by MLL3 and MLL4 complexes | 0.672970 | 0.172 |
R-HSA-9818564 | Epigenetic regulation of gene expression by MLL3 and MLL4 complexes | 0.672970 | 0.172 |
R-HSA-9679506 | SARS-CoV Infections | 0.675505 | 0.170 |
R-HSA-9843745 | Adipogenesis | 0.690824 | 0.161 |
R-HSA-446219 | Synthesis of substrates in N-glycan biosythesis | 0.690824 | 0.161 |
R-HSA-8856688 | Golgi-to-ER retrograde transport | 0.693294 | 0.159 |
R-HSA-9018519 | Estrogen-dependent gene expression | 0.705355 | 0.152 |
R-HSA-6807070 | PTEN Regulation | 0.712365 | 0.147 |
R-HSA-1632852 | Macroautophagy | 0.716946 | 0.145 |
R-HSA-74160 | Gene expression (Transcription) | 0.726198 | 0.139 |
R-HSA-199977 | ER to Golgi Anterograde Transport | 0.732416 | 0.135 |
R-HSA-166016 | Toll Like Receptor 4 (TLR4) Cascade | 0.734557 | 0.134 |
R-HSA-6798695 | Neutrophil degranulation | 0.735402 | 0.133 |
R-HSA-9010553 | Regulation of expression of SLITs and ROBOs | 0.742950 | 0.129 |
R-HSA-5693532 | DNA Double-Strand Break Repair | 0.745007 | 0.128 |
R-HSA-9917777 | Epigenetic regulation by WDR5-containing histone modifying complexes | 0.747047 | 0.127 |
R-HSA-73887 | Death Receptor Signaling | 0.747047 | 0.127 |
R-HSA-9612973 | Autophagy | 0.751080 | 0.124 |
R-HSA-446193 | Biosynthesis of the N-glycan precursor (dolichol lipid-linked oligosaccharide, L... | 0.753072 | 0.123 |
R-HSA-983705 | Signaling by the B Cell Receptor (BCR) | 0.755049 | 0.122 |
R-HSA-1852241 | Organelle biogenesis and maintenance | 0.755095 | 0.122 |
R-HSA-212165 | Epigenetic regulation of gene expression | 0.759408 | 0.120 |
R-HSA-109581 | Apoptosis | 0.762799 | 0.118 |
R-HSA-1280215 | Cytokine Signaling in Immune system | 0.774429 | 0.111 |
R-HSA-5621481 | C-type lectin receptors (CLRs) | 0.781126 | 0.107 |
R-HSA-9764274 | Regulation of Expression and Function of Type I Classical Cadherins | 0.784619 | 0.105 |
R-HSA-9764265 | Regulation of CDH1 Expression and Function | 0.784619 | 0.105 |
R-HSA-9678108 | SARS-CoV-1 Infection | 0.788057 | 0.103 |
R-HSA-201681 | TCF dependent signaling in response to WNT | 0.801272 | 0.096 |
R-HSA-3781865 | Diseases of glycosylation | 0.802866 | 0.095 |
R-HSA-73857 | RNA Polymerase II Transcription | 0.813560 | 0.090 |
R-HSA-168898 | Toll-like Receptor Cascades | 0.813670 | 0.090 |
R-HSA-9759476 | Regulation of Homotypic Cell-Cell Adhesion | 0.821025 | 0.086 |
R-HSA-6811442 | Intra-Golgi and retrograde Golgi-to-ER traffic | 0.826701 | 0.083 |
R-HSA-948021 | Transport to the Golgi and subsequent modification | 0.829472 | 0.081 |
R-HSA-422475 | Axon guidance | 0.831314 | 0.080 |
R-HSA-983169 | Class I MHC mediated antigen processing & presentation | 0.833887 | 0.079 |
R-HSA-5357801 | Programmed Cell Death | 0.834883 | 0.078 |
R-HSA-418990 | Adherens junctions interactions | 0.851317 | 0.070 |
R-HSA-9675108 | Nervous system development | 0.861838 | 0.065 |
R-HSA-446203 | Asparagine N-linked glycosylation | 0.869981 | 0.060 |
R-HSA-8939211 | ESR-mediated signaling | 0.872460 | 0.059 |
R-HSA-9006934 | Signaling by Receptor Tyrosine Kinases | 0.883604 | 0.054 |
R-HSA-421270 | Cell-cell junction organization | 0.886103 | 0.053 |
R-HSA-449147 | Signaling by Interleukins | 0.891183 | 0.050 |
R-HSA-71387 | Metabolism of carbohydrates and carbohydrate derivatives | 0.894778 | 0.048 |
R-HSA-9711123 | Cellular response to chemical stress | 0.900737 | 0.045 |
R-HSA-3700989 | Transcriptional Regulation by TP53 | 0.901384 | 0.045 |
R-HSA-199991 | Membrane Trafficking | 0.904495 | 0.044 |
R-HSA-446728 | Cell junction organization | 0.908457 | 0.042 |
R-HSA-983168 | Antigen processing: Ubiquitination & Proteasome degradation | 0.911375 | 0.040 |
R-HSA-5673001 | RAF/MAP kinase cascade | 0.916262 | 0.038 |
R-HSA-1257604 | PIP3 activates AKT signaling | 0.920237 | 0.036 |
R-HSA-1483257 | Phospholipid metabolism | 0.920237 | 0.036 |
R-HSA-5684996 | MAPK1/MAPK3 signaling | 0.920881 | 0.036 |
R-HSA-195721 | Signaling by WNT | 0.922154 | 0.035 |
R-HSA-1280218 | Adaptive Immune System | 0.931484 | 0.031 |
R-HSA-1500931 | Cell-Cell communication | 0.932732 | 0.030 |
R-HSA-112315 | Transmission across Chemical Synapses | 0.936449 | 0.029 |
R-HSA-162582 | Signal Transduction | 0.940192 | 0.027 |
R-HSA-9006925 | Intracellular signaling by second messengers | 0.945541 | 0.024 |
R-HSA-5683057 | MAPK family signaling cascades | 0.947711 | 0.023 |
R-HSA-73894 | DNA Repair | 0.952960 | 0.021 |
R-HSA-9006931 | Signaling by Nuclear Receptors | 0.954095 | 0.020 |
R-HSA-9824446 | Viral Infection Pathways | 0.954847 | 0.020 |
R-HSA-1266738 | Developmental Biology | 0.958535 | 0.018 |
R-HSA-168249 | Innate Immune System | 0.962166 | 0.017 |
R-HSA-5653656 | Vesicle-mediated transport | 0.963225 | 0.016 |
R-HSA-9824439 | Bacterial Infection Pathways | 0.963461 | 0.016 |
R-HSA-2262752 | Cellular responses to stress | 0.968538 | 0.014 |
R-HSA-168256 | Immune System | 0.969108 | 0.014 |
R-HSA-212436 | Generic Transcription Pathway | 0.971655 | 0.012 |
R-HSA-5668914 | Diseases of metabolism | 0.972990 | 0.012 |
R-HSA-72766 | Translation | 0.973428 | 0.012 |
R-HSA-112316 | Neuronal System | 0.980692 | 0.008 |
R-HSA-8953897 | Cellular responses to stimuli | 0.985217 | 0.006 |
R-HSA-5663202 | Diseases of signal transduction by growth factor receptors and second messengers | 0.986873 | 0.006 |
R-HSA-5663205 | Infectious disease | 0.994838 | 0.002 |
R-HSA-597592 | Post-translational protein modification | 0.998028 | 0.001 |
R-HSA-1643685 | Disease | 0.999866 | 0.000 |
R-HSA-392499 | Metabolism of proteins | 0.999952 | 0.000 |
R-HSA-556833 | Metabolism of lipids | 0.999997 | 0.000 |
R-HSA-1430728 | Metabolism | 1.000000 | 0.000 |
Download
kinase | JSD_mean | pearson_surrounding | kinase_max_IC_position | max_position_JSD |
---|---|---|---|---|
HIPK2 |
0.873 | 0.821 | 1 | 0.894 |
KIS |
0.861 | 0.760 | 1 | 0.879 |
HIPK1 |
0.854 | 0.783 | 1 | 0.833 |
CLK3 |
0.850 | 0.630 | 1 | 0.670 |
DYRK2 |
0.849 | 0.778 | 1 | 0.847 |
CDK10 |
0.849 | 0.793 | 1 | 0.900 |
CDK18 |
0.849 | 0.775 | 1 | 0.912 |
CDK19 |
0.845 | 0.748 | 1 | 0.898 |
DYRK1B |
0.845 | 0.767 | 1 | 0.874 |
DYRK4 |
0.843 | 0.762 | 1 | 0.908 |
P38G |
0.843 | 0.782 | 1 | 0.927 |
CDK17 |
0.842 | 0.771 | 1 | 0.922 |
SRPK1 |
0.842 | 0.515 | -3 | 0.841 |
CDK12 |
0.841 | 0.774 | 1 | 0.917 |
CDK1 |
0.841 | 0.746 | 1 | 0.903 |
HIPK4 |
0.841 | 0.603 | 1 | 0.685 |
CDK13 |
0.840 | 0.764 | 1 | 0.905 |
CDK8 |
0.840 | 0.738 | 1 | 0.881 |
HIPK3 |
0.839 | 0.756 | 1 | 0.812 |
ERK1 |
0.838 | 0.758 | 1 | 0.908 |
CDK7 |
0.838 | 0.740 | 1 | 0.890 |
CDK5 |
0.837 | 0.736 | 1 | 0.870 |
CLK2 |
0.837 | 0.562 | -3 | 0.836 |
CDK14 |
0.837 | 0.784 | 1 | 0.889 |
DYRK3 |
0.836 | 0.672 | 1 | 0.800 |
CDK16 |
0.835 | 0.749 | 1 | 0.918 |
DYRK1A |
0.835 | 0.681 | 1 | 0.830 |
CDK3 |
0.835 | 0.659 | 1 | 0.922 |
P38D |
0.833 | 0.758 | 1 | 0.933 |
SRPK2 |
0.833 | 0.453 | -3 | 0.789 |
MAK |
0.832 | 0.612 | -2 | 0.791 |
JNK2 |
0.832 | 0.759 | 1 | 0.919 |
P38B |
0.831 | 0.746 | 1 | 0.900 |
SRPK3 |
0.828 | 0.448 | -3 | 0.815 |
CDK9 |
0.828 | 0.740 | 1 | 0.901 |
CLK1 |
0.828 | 0.553 | -3 | 0.812 |
CDK4 |
0.827 | 0.775 | 1 | 0.919 |
JNK3 |
0.826 | 0.748 | 1 | 0.907 |
CLK4 |
0.826 | 0.533 | -3 | 0.840 |
NLK |
0.825 | 0.737 | 1 | 0.702 |
P38A |
0.824 | 0.730 | 1 | 0.854 |
CDK6 |
0.822 | 0.745 | 1 | 0.899 |
ERK2 |
0.820 | 0.736 | 1 | 0.880 |
MOK |
0.819 | 0.600 | 1 | 0.740 |
ICK |
0.817 | 0.498 | -3 | 0.881 |
CDKL5 |
0.815 | 0.329 | -3 | 0.861 |
CDKL1 |
0.809 | 0.317 | -3 | 0.862 |
ERK5 |
0.807 | 0.385 | 1 | 0.623 |
JNK1 |
0.804 | 0.658 | 1 | 0.915 |
MTOR |
0.801 | 0.244 | 1 | 0.514 |
AURC |
0.799 | 0.204 | -2 | 0.703 |
COT |
0.796 | -0.002 | 2 | 0.808 |
RSK2 |
0.796 | 0.186 | -3 | 0.849 |
CDK2 |
0.795 | 0.513 | 1 | 0.819 |
PRP4 |
0.795 | 0.455 | -3 | 0.739 |
PIM3 |
0.793 | 0.126 | -3 | 0.885 |
MOS |
0.791 | 0.078 | 1 | 0.407 |
RSK3 |
0.791 | 0.163 | -3 | 0.839 |
ERK7 |
0.790 | 0.332 | 2 | 0.632 |
PKCD |
0.790 | 0.141 | 2 | 0.770 |
PKN3 |
0.790 | 0.111 | -3 | 0.859 |
P90RSK |
0.790 | 0.168 | -3 | 0.854 |
PIM1 |
0.790 | 0.177 | -3 | 0.856 |
NDR2 |
0.789 | 0.093 | -3 | 0.873 |
NUAK2 |
0.789 | 0.139 | -3 | 0.875 |
AKT2 |
0.789 | 0.223 | -3 | 0.791 |
NDR1 |
0.789 | 0.113 | -3 | 0.865 |
CDC7 |
0.788 | -0.030 | 1 | 0.365 |
PRKX |
0.788 | 0.212 | -3 | 0.785 |
PKACG |
0.788 | 0.145 | -2 | 0.709 |
PRKD2 |
0.788 | 0.154 | -3 | 0.834 |
PKACB |
0.788 | 0.204 | -2 | 0.686 |
WNK1 |
0.787 | 0.069 | -2 | 0.792 |
PKN2 |
0.786 | 0.109 | -3 | 0.845 |
MST4 |
0.786 | 0.076 | 2 | 0.822 |
RSK4 |
0.786 | 0.187 | -3 | 0.841 |
ATR |
0.785 | 0.032 | 1 | 0.417 |
CAMK1B |
0.785 | 0.108 | -3 | 0.867 |
PKCA |
0.785 | 0.152 | 2 | 0.731 |
CAMLCK |
0.784 | 0.166 | -2 | 0.805 |
AURB |
0.784 | 0.173 | -2 | 0.696 |
AKT1 |
0.784 | 0.220 | -3 | 0.801 |
SKMLCK |
0.784 | 0.094 | -2 | 0.828 |
GCN2 |
0.783 | -0.089 | 2 | 0.785 |
P70S6KB |
0.783 | 0.152 | -3 | 0.845 |
PKCG |
0.783 | 0.131 | 2 | 0.733 |
MNK1 |
0.783 | 0.149 | -2 | 0.759 |
CHAK2 |
0.782 | 0.024 | -1 | 0.847 |
NIK |
0.782 | 0.124 | -3 | 0.856 |
TGFBR2 |
0.781 | -0.013 | -2 | 0.722 |
DAPK2 |
0.781 | 0.145 | -3 | 0.870 |
IRE1 |
0.781 | 0.058 | 1 | 0.343 |
PRPK |
0.781 | -0.067 | -1 | 0.826 |
PIM2 |
0.781 | 0.214 | -3 | 0.821 |
PAK1 |
0.781 | 0.123 | -2 | 0.791 |
NEK6 |
0.781 | -0.005 | -2 | 0.734 |
PRKD1 |
0.780 | 0.086 | -3 | 0.857 |
GRK1 |
0.780 | 0.046 | -2 | 0.749 |
TBK1 |
0.780 | -0.113 | 1 | 0.322 |
PKG2 |
0.780 | 0.154 | -2 | 0.671 |
RAF1 |
0.779 | -0.097 | 1 | 0.361 |
PAK6 |
0.779 | 0.140 | -2 | 0.723 |
MLK3 |
0.779 | 0.055 | 2 | 0.737 |
PKCB |
0.779 | 0.108 | 2 | 0.728 |
PHKG1 |
0.779 | 0.091 | -3 | 0.853 |
SGK3 |
0.779 | 0.163 | -3 | 0.825 |
MLK1 |
0.778 | -0.017 | 2 | 0.783 |
PKCZ |
0.778 | 0.107 | 2 | 0.780 |
MNK2 |
0.778 | 0.102 | -2 | 0.756 |
MAPKAPK3 |
0.777 | 0.077 | -3 | 0.829 |
IKKB |
0.777 | -0.107 | -2 | 0.615 |
PAK3 |
0.777 | 0.093 | -2 | 0.770 |
PRKD3 |
0.776 | 0.131 | -3 | 0.808 |
GRK7 |
0.776 | 0.060 | 1 | 0.377 |
MSK2 |
0.776 | 0.132 | -3 | 0.830 |
BMPR2 |
0.775 | -0.096 | -2 | 0.761 |
RIPK3 |
0.775 | -0.065 | 3 | 0.667 |
AURA |
0.775 | 0.145 | -2 | 0.702 |
IKKE |
0.774 | -0.135 | 1 | 0.318 |
MPSK1 |
0.774 | 0.148 | 1 | 0.390 |
IRE2 |
0.774 | 0.051 | 2 | 0.739 |
PKCH |
0.774 | 0.108 | 2 | 0.716 |
AMPKA1 |
0.774 | 0.036 | -3 | 0.866 |
AKT3 |
0.774 | 0.214 | -3 | 0.754 |
MAPKAPK2 |
0.773 | 0.082 | -3 | 0.815 |
AMPKA2 |
0.773 | 0.066 | -3 | 0.853 |
PKCE |
0.773 | 0.190 | 2 | 0.730 |
LATS2 |
0.772 | 0.029 | -5 | 0.720 |
MSK1 |
0.772 | 0.147 | -3 | 0.827 |
PDHK4 |
0.772 | -0.179 | 1 | 0.423 |
DSTYK |
0.772 | -0.122 | 2 | 0.838 |
LATS1 |
0.772 | 0.103 | -3 | 0.884 |
PKACA |
0.772 | 0.181 | -2 | 0.647 |
PAK2 |
0.772 | 0.102 | -2 | 0.776 |
ULK2 |
0.771 | -0.170 | 2 | 0.759 |
NEK7 |
0.770 | -0.124 | -3 | 0.784 |
PKCT |
0.770 | 0.123 | 2 | 0.720 |
GRK5 |
0.770 | -0.095 | -3 | 0.804 |
MYLK4 |
0.769 | 0.127 | -2 | 0.770 |
PKCI |
0.768 | 0.148 | 2 | 0.756 |
WNK3 |
0.768 | -0.109 | 1 | 0.357 |
PKR |
0.768 | 0.047 | 1 | 0.374 |
MLK2 |
0.768 | -0.067 | 2 | 0.791 |
SGK1 |
0.766 | 0.209 | -3 | 0.740 |
MLK4 |
0.766 | 0.003 | 2 | 0.713 |
CAMK2G |
0.766 | -0.114 | 2 | 0.766 |
PDHK1 |
0.766 | -0.184 | 1 | 0.401 |
TTBK2 |
0.766 | -0.106 | 2 | 0.704 |
RIPK1 |
0.766 | -0.101 | 1 | 0.350 |
CAMK4 |
0.766 | 0.021 | -3 | 0.838 |
CHAK1 |
0.766 | -0.019 | 2 | 0.786 |
NUAK1 |
0.765 | 0.035 | -3 | 0.834 |
BMPR1B |
0.765 | -0.022 | 1 | 0.320 |
PAK5 |
0.765 | 0.128 | -2 | 0.681 |
PINK1 |
0.764 | 0.194 | 1 | 0.536 |
MELK |
0.764 | 0.025 | -3 | 0.834 |
DLK |
0.764 | -0.107 | 1 | 0.369 |
ANKRD3 |
0.764 | -0.091 | 1 | 0.382 |
TSSK1 |
0.764 | -0.000 | -3 | 0.880 |
NEK9 |
0.763 | -0.132 | 2 | 0.816 |
PAK4 |
0.763 | 0.130 | -2 | 0.702 |
MST3 |
0.763 | 0.092 | 2 | 0.816 |
HUNK |
0.763 | -0.143 | 2 | 0.756 |
CAMK2D |
0.762 | -0.057 | -3 | 0.846 |
CK1E |
0.762 | 0.054 | -3 | 0.583 |
TAO3 |
0.762 | 0.086 | 1 | 0.378 |
MARK4 |
0.762 | -0.080 | 4 | 0.754 |
NIM1 |
0.762 | -0.052 | 3 | 0.687 |
DCAMKL1 |
0.761 | 0.070 | -3 | 0.837 |
IKKA |
0.761 | -0.108 | -2 | 0.606 |
CAMK1G |
0.761 | 0.078 | -3 | 0.821 |
PHKG2 |
0.760 | 0.079 | -3 | 0.815 |
BUB1 |
0.760 | 0.163 | -5 | 0.749 |
MRCKB |
0.760 | 0.191 | -3 | 0.800 |
PKN1 |
0.760 | 0.132 | -3 | 0.798 |
P70S6K |
0.760 | 0.125 | -3 | 0.788 |
MASTL |
0.760 | -0.176 | -2 | 0.695 |
CK1D |
0.759 | 0.084 | -3 | 0.534 |
VRK2 |
0.759 | 0.050 | 1 | 0.455 |
QSK |
0.759 | 0.006 | 4 | 0.736 |
ALK4 |
0.759 | -0.067 | -2 | 0.718 |
WNK4 |
0.759 | 0.008 | -2 | 0.775 |
BCKDK |
0.759 | -0.159 | -1 | 0.754 |
ATM |
0.759 | -0.068 | 1 | 0.379 |
DAPK3 |
0.759 | 0.156 | -3 | 0.853 |
ROCK2 |
0.758 | 0.186 | -3 | 0.839 |
CAMK2A |
0.758 | 0.022 | 2 | 0.746 |
GRK4 |
0.758 | -0.121 | -2 | 0.758 |
ULK1 |
0.758 | -0.188 | -3 | 0.743 |
SMMLCK |
0.758 | 0.131 | -3 | 0.846 |
QIK |
0.758 | -0.038 | -3 | 0.835 |
SIK |
0.757 | 0.025 | -3 | 0.813 |
GSK3A |
0.757 | 0.164 | 4 | 0.383 |
NEK2 |
0.757 | -0.057 | 2 | 0.813 |
PERK |
0.757 | -0.042 | -2 | 0.740 |
TSSK2 |
0.757 | -0.061 | -5 | 0.778 |
GRK6 |
0.757 | -0.128 | 1 | 0.358 |
YSK4 |
0.756 | -0.103 | 1 | 0.331 |
DNAPK |
0.756 | -0.036 | 1 | 0.386 |
HASPIN |
0.755 | 0.139 | -1 | 0.768 |
IRAK4 |
0.755 | -0.028 | 1 | 0.334 |
MAPKAPK5 |
0.755 | 0.024 | -3 | 0.797 |
CAMK2B |
0.754 | -0.035 | 2 | 0.729 |
MEK5 |
0.753 | -0.034 | 2 | 0.778 |
DMPK1 |
0.753 | 0.218 | -3 | 0.818 |
ACVR2A |
0.753 | -0.073 | -2 | 0.697 |
BRSK1 |
0.753 | 0.004 | -3 | 0.835 |
CHK2 |
0.753 | 0.143 | -3 | 0.742 |
MEKK1 |
0.753 | -0.064 | 1 | 0.360 |
SMG1 |
0.753 | -0.070 | 1 | 0.393 |
MEKK2 |
0.753 | -0.027 | 2 | 0.772 |
PASK |
0.752 | 0.061 | -3 | 0.892 |
ACVR2B |
0.752 | -0.075 | -2 | 0.702 |
BRSK2 |
0.752 | -0.036 | -3 | 0.831 |
CK1A2 |
0.752 | 0.054 | -3 | 0.539 |
DAPK1 |
0.752 | 0.139 | -3 | 0.846 |
TGFBR1 |
0.752 | -0.093 | -2 | 0.691 |
KHS2 |
0.751 | 0.135 | 1 | 0.364 |
MEK1 |
0.751 | -0.135 | 2 | 0.785 |
SBK |
0.751 | 0.230 | -3 | 0.703 |
TAO2 |
0.751 | 0.072 | 2 | 0.822 |
DRAK1 |
0.751 | -0.075 | 1 | 0.331 |
PDK1 |
0.751 | 0.049 | 1 | 0.400 |
MRCKA |
0.750 | 0.155 | -3 | 0.812 |
ZAK |
0.750 | -0.086 | 1 | 0.342 |
GRK2 |
0.750 | -0.061 | -2 | 0.639 |
TNIK |
0.749 | 0.090 | 3 | 0.839 |
HRI |
0.749 | -0.087 | -2 | 0.741 |
MEKK3 |
0.749 | -0.086 | 1 | 0.355 |
CRIK |
0.749 | 0.191 | -3 | 0.806 |
GCK |
0.749 | 0.052 | 1 | 0.357 |
NEK5 |
0.748 | -0.084 | 1 | 0.357 |
TLK2 |
0.748 | -0.122 | 1 | 0.343 |
DCAMKL2 |
0.748 | 0.014 | -3 | 0.840 |
HPK1 |
0.748 | 0.070 | 1 | 0.359 |
KHS1 |
0.748 | 0.092 | 1 | 0.352 |
PLK1 |
0.748 | -0.154 | -2 | 0.690 |
NEK8 |
0.747 | -0.020 | 2 | 0.795 |
CK1G1 |
0.747 | 0.001 | -3 | 0.566 |
ROCK1 |
0.747 | 0.181 | -3 | 0.810 |
HGK |
0.747 | 0.056 | 3 | 0.842 |
SNRK |
0.747 | -0.085 | 2 | 0.635 |
CAMK1D |
0.746 | 0.089 | -3 | 0.771 |
LOK |
0.746 | 0.060 | -2 | 0.655 |
ALK2 |
0.745 | -0.098 | -2 | 0.708 |
CHK1 |
0.744 | -0.044 | -3 | 0.838 |
FAM20C |
0.744 | -0.045 | 2 | 0.575 |
GAK |
0.743 | 0.016 | 1 | 0.395 |
MAP3K15 |
0.743 | -0.017 | 1 | 0.351 |
SLK |
0.743 | 0.034 | -2 | 0.606 |
LRRK2 |
0.743 | 0.096 | 2 | 0.827 |
LKB1 |
0.743 | -0.007 | -3 | 0.786 |
NEK11 |
0.743 | -0.076 | 1 | 0.377 |
BMPR1A |
0.743 | -0.066 | 1 | 0.304 |
PLK4 |
0.742 | -0.143 | 2 | 0.586 |
MINK |
0.742 | 0.002 | 1 | 0.337 |
SSTK |
0.742 | -0.027 | 4 | 0.730 |
MARK3 |
0.742 | -0.062 | 4 | 0.686 |
MEKK6 |
0.742 | -0.007 | 1 | 0.352 |
PKG1 |
0.741 | 0.111 | -2 | 0.601 |
CAMK1A |
0.741 | 0.107 | -3 | 0.746 |
PBK |
0.740 | 0.030 | 1 | 0.354 |
BRAF |
0.740 | -0.143 | -4 | 0.776 |
EEF2K |
0.739 | 0.024 | 3 | 0.785 |
GSK3B |
0.739 | 0.021 | 4 | 0.375 |
GRK3 |
0.738 | -0.058 | -2 | 0.617 |
MARK2 |
0.737 | -0.091 | 4 | 0.649 |
TLK1 |
0.737 | -0.146 | -2 | 0.727 |
TTBK1 |
0.737 | -0.136 | 2 | 0.619 |
PLK3 |
0.736 | -0.163 | 2 | 0.713 |
NEK4 |
0.735 | -0.096 | 1 | 0.336 |
YSK1 |
0.735 | 0.012 | 2 | 0.800 |
MARK1 |
0.734 | -0.096 | 4 | 0.709 |
NEK1 |
0.733 | -0.069 | 1 | 0.337 |
TAK1 |
0.731 | -0.085 | 1 | 0.351 |
IRAK1 |
0.729 | -0.197 | -1 | 0.749 |
TAO1 |
0.729 | 0.039 | 1 | 0.333 |
STK33 |
0.729 | -0.074 | 2 | 0.600 |
CAMKK1 |
0.728 | -0.186 | -2 | 0.612 |
MYO3B |
0.728 | 0.065 | 2 | 0.820 |
CAMKK2 |
0.728 | -0.134 | -2 | 0.617 |
MST2 |
0.728 | -0.127 | 1 | 0.347 |
OSR1 |
0.727 | 0.012 | 2 | 0.769 |
TTK |
0.727 | 0.009 | -2 | 0.741 |
VRK1 |
0.726 | -0.131 | 2 | 0.790 |
MST1 |
0.724 | -0.098 | 1 | 0.336 |
NEK3 |
0.722 | -0.080 | 1 | 0.348 |
CK1A |
0.721 | 0.032 | -3 | 0.451 |
BIKE |
0.720 | -0.009 | 1 | 0.352 |
MYO3A |
0.720 | 0.007 | 1 | 0.346 |
YANK3 |
0.719 | -0.014 | 2 | 0.398 |
ASK1 |
0.719 | -0.059 | 1 | 0.349 |
CK2A2 |
0.718 | -0.097 | 1 | 0.278 |
RIPK2 |
0.717 | -0.185 | 1 | 0.321 |
AAK1 |
0.716 | 0.027 | 1 | 0.329 |
LIMK2_TYR |
0.715 | 0.228 | -3 | 0.839 |
MEK2 |
0.715 | -0.205 | 2 | 0.765 |
PDHK3_TYR |
0.713 | 0.145 | 4 | 0.840 |
PLK2 |
0.712 | -0.109 | -3 | 0.717 |
TESK1_TYR |
0.711 | 0.140 | 3 | 0.802 |
CK2A1 |
0.710 | -0.103 | 1 | 0.266 |
PDHK4_TYR |
0.707 | 0.096 | 2 | 0.812 |
PKMYT1_TYR |
0.707 | 0.149 | 3 | 0.775 |
ALPHAK3 |
0.706 | -0.072 | -1 | 0.714 |
PINK1_TYR |
0.704 | 0.046 | 1 | 0.412 |
MAP2K4_TYR |
0.704 | 0.055 | -1 | 0.827 |
RET |
0.701 | -0.031 | 1 | 0.380 |
MAP2K7_TYR |
0.700 | -0.040 | 2 | 0.805 |
LIMK1_TYR |
0.700 | 0.072 | 2 | 0.819 |
MAP2K6_TYR |
0.700 | 0.019 | -1 | 0.835 |
CK1G3 |
0.699 | 0.023 | -3 | 0.407 |
BMPR2_TYR |
0.699 | 0.015 | -1 | 0.819 |
MST1R |
0.698 | -0.029 | 3 | 0.767 |
PDHK1_TYR |
0.698 | -0.030 | -1 | 0.831 |
ABL2 |
0.698 | -0.013 | -1 | 0.749 |
CSF1R |
0.697 | -0.039 | 3 | 0.752 |
TNK1 |
0.696 | 0.031 | 3 | 0.737 |
ROS1 |
0.695 | -0.069 | 3 | 0.731 |
JAK2 |
0.694 | -0.080 | 1 | 0.387 |
TYK2 |
0.693 | -0.129 | 1 | 0.368 |
JAK1 |
0.692 | -0.020 | 1 | 0.345 |
TYRO3 |
0.692 | -0.105 | 3 | 0.758 |
TNNI3K_TYR |
0.692 | 0.036 | 1 | 0.385 |
LCK |
0.692 | -0.020 | -1 | 0.783 |
STLK3 |
0.691 | -0.184 | 1 | 0.321 |
TNK2 |
0.691 | -0.047 | 3 | 0.698 |
ABL1 |
0.691 | -0.040 | -1 | 0.740 |
NEK10_TYR |
0.691 | -0.034 | 1 | 0.338 |
EPHA6 |
0.690 | -0.081 | -1 | 0.786 |
KDR |
0.689 | -0.024 | 3 | 0.691 |
FGR |
0.688 | -0.094 | 1 | 0.350 |
EPHB4 |
0.688 | -0.101 | -1 | 0.761 |
BLK |
0.688 | -0.027 | -1 | 0.777 |
JAK3 |
0.688 | -0.090 | 1 | 0.370 |
TXK |
0.688 | -0.057 | 1 | 0.327 |
YES1 |
0.688 | -0.075 | -1 | 0.805 |
WEE1_TYR |
0.687 | 0.016 | -1 | 0.721 |
MET |
0.686 | -0.050 | 3 | 0.740 |
FLT3 |
0.685 | -0.091 | 3 | 0.762 |
KIT |
0.685 | -0.086 | 3 | 0.741 |
PDGFRB |
0.684 | -0.119 | 3 | 0.755 |
YANK2 |
0.684 | -0.044 | 2 | 0.415 |
FGFR2 |
0.684 | -0.051 | 3 | 0.701 |
DDR1 |
0.683 | -0.119 | 4 | 0.774 |
INSRR |
0.683 | -0.119 | 3 | 0.676 |
HCK |
0.682 | -0.116 | -1 | 0.780 |
ITK |
0.681 | -0.112 | -1 | 0.756 |
FER |
0.679 | -0.178 | 1 | 0.365 |
CK1G2 |
0.679 | 0.003 | -3 | 0.491 |
PDGFRA |
0.679 | -0.141 | 3 | 0.759 |
FGFR1 |
0.678 | -0.087 | 3 | 0.693 |
TEK |
0.678 | -0.065 | 3 | 0.671 |
DDR2 |
0.676 | -0.009 | 3 | 0.652 |
FYN |
0.676 | -0.067 | -1 | 0.769 |
FLT1 |
0.675 | -0.084 | -1 | 0.753 |
BMX |
0.675 | -0.099 | -1 | 0.679 |
ALK |
0.675 | -0.123 | 3 | 0.664 |
MERTK |
0.675 | -0.144 | 3 | 0.711 |
AXL |
0.674 | -0.165 | 3 | 0.715 |
TEC |
0.673 | -0.117 | -1 | 0.684 |
SRMS |
0.672 | -0.200 | 1 | 0.339 |
EPHA4 |
0.672 | -0.122 | 2 | 0.713 |
EPHB1 |
0.672 | -0.195 | 1 | 0.344 |
BTK |
0.671 | -0.178 | -1 | 0.731 |
FGFR3 |
0.670 | -0.088 | 3 | 0.667 |
FRK |
0.670 | -0.132 | -1 | 0.769 |
EPHB3 |
0.670 | -0.186 | -1 | 0.743 |
EPHA1 |
0.669 | -0.130 | 3 | 0.727 |
LTK |
0.669 | -0.144 | 3 | 0.671 |
EPHB2 |
0.668 | -0.180 | -1 | 0.730 |
MATK |
0.668 | -0.082 | -1 | 0.670 |
ERBB2 |
0.667 | -0.155 | 1 | 0.343 |
LYN |
0.666 | -0.135 | 3 | 0.668 |
INSR |
0.666 | -0.167 | 3 | 0.666 |
FLT4 |
0.665 | -0.150 | 3 | 0.664 |
EPHA7 |
0.665 | -0.147 | 2 | 0.720 |
PTK6 |
0.664 | -0.200 | -1 | 0.693 |
EGFR |
0.663 | -0.110 | 1 | 0.304 |
PTK2B |
0.663 | -0.111 | -1 | 0.722 |
SYK |
0.663 | -0.048 | -1 | 0.704 |
NTRK2 |
0.663 | -0.214 | 3 | 0.697 |
NTRK1 |
0.663 | -0.228 | -1 | 0.759 |
SRC |
0.662 | -0.124 | -1 | 0.755 |
PTK2 |
0.662 | -0.048 | -1 | 0.730 |
ZAP70 |
0.660 | -0.005 | -1 | 0.651 |
NTRK3 |
0.660 | -0.171 | -1 | 0.715 |
MUSK |
0.658 | -0.110 | 1 | 0.288 |
EPHA3 |
0.658 | -0.178 | 2 | 0.690 |
EPHA8 |
0.657 | -0.134 | -1 | 0.727 |
FGFR4 |
0.656 | -0.121 | -1 | 0.688 |
CSK |
0.654 | -0.171 | 2 | 0.721 |
EPHA5 |
0.653 | -0.174 | 2 | 0.688 |
ERBB4 |
0.651 | -0.099 | 1 | 0.304 |
IGF1R |
0.650 | -0.158 | 3 | 0.597 |
EPHA2 |
0.645 | -0.152 | -1 | 0.690 |
FES |
0.628 | -0.192 | -1 | 0.651 |